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Als meus pares 
  
ABSTRACT 
 
Historically, most scientific discoveries have been accompanied by previous 
technological innovation. Representative examples are the introduction of gene 
sequencing technologies, which allowed for the mapping of the human genome, or the 
constant improvement in the microscopy field that lead to the introduction of modern 
multiphoton imaging techniques, allowing for live imaging of body organs in animal 
specimens. In this regard, the molecular imaging of analytes in tissue has traditionally 
been a challenging field. For instance, mass spectrometric techniques did not initially 
allow for the imaging of compounds in a given sample. Technological improvement 
lead to the introduction of instruments that could transform the spectra acquired from 
samples into images of the distribution of surface analytes. In the present thesis work, 
we approach the study of biological samples using Time-of-Flight Secondary Ion Mass 
Spectrometry (ToF-SIMS), a surface imaging technique specially suited for the 
imaging of lipids and lipid precursors in biological tissue. Our project started with the 
optimization of ToF-SIMS protocols for the study of mouse brain and fat adipose 
tissues, which allowed us to learn ways to systematically process biological material in 
a reliable and reproducible manner. Next, we focused our efforts on the application of 
ToF-SIMS to the study of a well established biological problem: Alzheimer’s disease.  
We developed a methodology combining ToF-SIMS with fluorescence imaging 
techniques in order to visualize lipids, lipid precursors and cell populations in brain 
regions undergoing senile plaque deposition. This multiplexed imaging approach 
enabled us to simultaneously observe lipid and glial cell distributions in regions 
undergoing senile plaque deposition with great lateral (<500 nm) resolution, and 
revealed micrometer-sized cholesterol accumulations in hippocampal regions occupied 
with senile plaques likely to mirror an AD-related pathological event. The systematic 
study of brain tissue sections from mouse models of Alzheimer’s disease followed; we 
investigated the cholesterol profile of brain regions occupied by senile plaques and 
compared it to that of wild-type, control brain. Regions undergoing plaque deposition 
displayed, often, severe cholesterol granulation, whereas regions devoid of plaques 
displayed a homogeneous sterol profile. Furthermore, investigation of glial profiles 
revealed increased astrocytic immunoreactivity in regions associated to cholesterol 
granulation, which was consistent with the already known role played by astrocytes 
during central nervous system injury. Besides cholesterol, other lipid compounds were 
studied, such as sulfatides and fatty acids, revealing specific surface distributions 
associated to distinct tissue structures. Given the growing attention paid to the 
involvement of lipids and lipid precursors in health and disease, tools that allow for the 
study of such compounds might play a vital role in the understanding of disease 
pathogenesis.  The implementation of technological improvements that allowed for 
the study of biological samples, with reduced analyte fragmentation and increased 
efficiencies, lead to the modern “ToF-SIMS imaging” concept presented in this thesis 
work. The current sensitivity and resolution are sufficient for cellular imaging of many 
lipids of likely pathophysiological importance. 
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INTRODUCTION 
This thesis work will mainly focus on the study of the lipid-related structures 
cholesterol (Ch) and sulfatides (ST), in the context of Alzheimer’s disease (AD), 
using imaging techniques. Therefore, the roles played by these two compounds in the 
central nervous system (CNS) and during AD pathogenesis will be extensively 
discussed herein. The involvement of other lipid structures such as phospholipids 
(Pettegrew et al., 2001; Farooqui et al., 2004; Pai et al., 2006), fatty acids (Zamaria, 
2004; Hooijmans and Kiliaan, 2007; Wang et al., 2008), gangliosides (Molander-
Melin et al., 2005; Ariga et al., 2008), prostaglandins (Bazan et al., 2002; Zagol-
Ikapitte et al., 2005; Hoshino et al., 2007), sphingolipids (Mutoh et al., 2006; Katsel 
et al., 2007) and others (Dietschy and Turley, 2004; Hartmann et al., 2006; Hirsch-
Reinshagen et al., 2009) in AD is out of the scope of the present work and has been 
extensively discussed elsewhere. 
 
CHOLESTEROL IN THE CENTRAL NERVOUS SYSTEM 
 
Distribution 
The sterols, of which Ch and its derivatives are the most widely studied in 
mammalian systems, constitute an important component of membrane lipids, along 
with the glycerophospholipids and sphingomyelins (Bach and Wachtel, 2003). In the 
CNS, Ch is mainly present as a free, non-esterified molecule (UCh), whereas the 
fraction of esterified cholesterol (ECh), stored in lipid droplets in neurons and glia, is 
comparatively much smaller. UCh plays an essential role in controlling the electrical 
properties of many cellular membranes, including the plasma membrane, as well as 
determining their fluidity and permeability characteristics, which has implications on 
the development and maintenance of neuronal plasticity (Ledesma and Dotti, 2006). 
Due to the brain’s unique anatomy and the relative isolation from the rest of the body, 
many properties of Ch metabolism in the CNS are unique compared to other organs. 
One of the most striking differences is the distribution of Ch in brain and spinal cord; 
besides being present in the plasma membrane of neurons and glial cells, Ch is mainly 
stored in the form of myelin sheaths, which are synthesized mainly by oligodendrocytes 
and further wrapped and dehydrated around numerous adjacent neurons to form 
compact sheets (Dietschy and Turley, 2004; Dietschy, 2009). Myelin is mainly 
composed of Ch, phospholipids and glycolipids, as is the case for most plasma 
membranes. However, the lipid content in myelin is much higher as compared to 
cellular plasma membranes. Myelin forms thick layers that insulate the hydrophobic 
membranes of the axons and reduce their capacitance; the need for such nerve 
insulation may be explained in the grounds of evolution of larger organisms and the 
subsequent need of increasing the speed of electrical conduction along neurons. As a 
result, axons acquire higher capacity for transmission of electrical signals (Dietschy, 
2009). Hence, CNS Ch is divided into two main pools consisting of i) the Ch in the 
plasma membranes of glial cells and neurons and ii) the Ch present in the specialized 
membranes of myelin, whereas in the other organs of the body Ch is mostly found in 
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the plasma membrane of cells, with the exception of fat adipose tissue. The CNS 
contains almost a 25% of the UCh present in the body, even though the organ accounts 
only for 2% of the body mass. 
 
Transport and supply  
In vertebrates, lipids are almost entirely transported by spherical particles containing 
apolipoproteins, phospholipids, fatty acids and Ch called lipoproteins (Christopher K. 
Mathews, 1990). During lipid mobilization, Ch is rapidly esterified and transported 
condensed within the lipoprotein core, of hydrophobic nature, whereas the outer layer 
of the particle is of hydrophilic nature, containing the phospholipids head group and 
UCh. The apolipoprotein is embedded into the structure, acting as a ligand that 
facilitates the recognition of the lipid particle by lipid receptors expressed at the cell 
surface. ApoE is a ligand for receptors of the low density lipoprotein receptor 
superfamily such as the low density lipoprotein receptor (LDLr), the low density 
lipoprotein receptor-related protein (LRP), the very low density lipoprotein receptor 
(VLDLr) and the apoE2 receptor, all of them expressed in the plasma membrane of 
CNS neurons (Herz and Beffert, 2000). The density of lipoproteins is inversely related 
to the capacity of the particles to transport Ch (and lipids). High density particles are 
very rich in apolipoprotein content and less rich in lipids, whereas low density 
lipoproteins carry higher amounts of lipids and Ch and have a lower content in 
apolipoproteins (Christopher K. Mathews, 1990). 
It has been proposed that, after differentiation of astrocytes, neurons reduce their 
endogenous production of Ch and rely mainly on Ch delivery from astrocytes via 
lipoprotein-like particles that contain astroglia-derived apoE (Argmann et al., 2005). 
Astrocytes have been shown to synthesize Ch and apoE under the influence of ATP-
binding cassette transporters (ABC), which facilitate the efflux of Ch to apoE and 
apoA-I-bearing lipoproteins (Wahrle et al., 2004; Karten et al., 2005; Abildayeva et 
al., 2006), being the predominant source of apoE in the brain. Microglia are also 
capable of synthesizing apoE, however, to a much lesser extent (Martins et al., 2008).  
Astrocytes secrete Ch, phospholipids and apoE in the form of small, high density 
lipoprotein (HDL) particles into the pericellular fluid (Gong et al., 2002; Dietschy, 
2009). These are taken up by neurons and other glial cells at especially high rates 
during development, regeneration after injury, or during the formation of new 
synaptic contacts. These lipoproteins are recognized by their specific membrane 
receptors and subsequently internalized via endocytosis (coated pit pathway). Once 
internalized, the lipoprotein-receptor unit undergoes hydrolysis by a neutral 
cholesteryl-ester hydrolase (Acton et al., 1996). Ch is transported from the lysosomal 
to the metabolically active pool in a process mediated by functional Niemann-Pick 
type C protein 1 (NPC1) transport system (Dietschy and Turley, 2001; Xie et al., 
2006). Figure 1-1 presents a speculative scheme on the transport and uptake pathways 
of Ch in the CNS.  
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The CNS is provided with Ch by de novo synthesis but mainly by recycling of 
existing sterol reservoirs (Shobab et al., 2005). Oligodendrocytes (Dietschy, 2009) 
and astrocytes (Pfrieger, 2003) account for the major part of Ch synthesis carried out 
in the CNS. Nevertheless, despite the fact that in vivo measurements of net Ch 
movement into the brain have not succeeded, there may be a small transfer of Ch 
from circulating plasma across the blood-brain barrier (BBB) as suggested by the 
presence of LDLRs and other lipoprotein transporters such as scavenger receptor 
class 1 (SR-B1) and ABC-A1 transporters in brain endothelial cells (Dehouck et al., 
1997; Dietschy, 2009).  
 
Uptake and recycling by glial cells 
Astrocytes and microglia are supporting cells that undertake several different 
functions in the CNS. Astrocytes supply nutrients to the nervous tissue, maintain the 
extracellular ion balance and play an important role in the repair and scarring process 
of the brain and spinal cord following traumatic injuries (Kandel, 1991). In contrast, 
microglia are the main immune cells of the brain (Nimmerjahn et al., 2005). Under 
nonpathological conditions, microglia are highly ramified cells. When activated by 
injury or insult to the brain, microglia proliferate, undergo morphological changes, 
and secrete chemokines and cytokines (Lucin and Wyss-Coray, 2009).  
In the event of neuronal loss and synaptic degeneration, astrocytes gather around the 
affected areas and recycle Ch and lipid fragments resulting from plasma and myelin 
membrane damage (Shobab et al., 2005). ApoE synthesis dramatically increases in 
glial cells recruited around the lesioned region, probably in order to facilitate lipid 
uptake (Poirier et al., 1991; Hayashi et al., 2004). Astrocytes not only recycle lipid 
and Ch debris from lesioned regions; they are capable of transporting large amounts 
of lipids to regions undergoing reinnervation (Poirier et al., 1993). In contrast, despite 
their capacity for synthesizing apoE, it is not clear whether microglia are able to 
secrete or internalize Ch in significant amounts (Gilardi et al., 2009). 
 
Clearance through the blood-brain barrier 
The Ch turnover in brain is remarkably slower than the turnover in all other organs. 
From 0.02% (human) up to 0.4% (mouse) of the Ch stored in the CNS is replaced 
each day. Accordingly, the absolute flux of Ch is approximately 0.9% as fast as the 
turnover of sterol in the whole body in these species. A fraction of the Ch levels in the 
plasma membrane of neurons and glial cells is constantly being replaced (e.g. 7-9% in 
mouse brain and 0,7% in human, daily) (Dietschy and Turley, 2001; Dietschy, 2009).  
In order to maintain Ch levels at steady state, it is necessary to maintain a balance 
between the newly incorporated and excreted sterol pools. Clearance is accomplished 
partly via conversion of Ch into 24(S)-hydroxycholesterol (24OHCh) and further 
excretion through the BBB (Björkhem and Meaney, 2004). Cholesterol 24-
hydroxylase (24OHChSE) is the enzyme responsible for the selective hydroxylation 
of Ch and is uniquely expressed in the brain (Lund et al., 1999). Due to the addition 
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of an oxygen atom into the structure, 24OHCh is a far more polar molecule than Ch 
and, as a result, it can easily go across the BBB and possibly the neuronal plasma 
membrane without any further transport mechanisms. 
Animal studies have shown that the amount of Ch excreted from the CNS is of about 
1,4 mg/day, 0,9 mg/day being excreted via formation of 24OHCh (Dietschy, 2009). 
In humans, the brain releases approximately 6 mg of 24SOHC into the periphery each 
day, which is subsequently uptaken by the liver (Björkhem et al., 1999). 
Furthermore, 24OHCh acts as a signaling molecule that induces the apoE-mediated 
Ch efflux from astrocytes but not from neurons. Therefore, large amounts of 24OHCh 
may induce de novo Ch synthesis by astrocytes, as means of maintaining the sterol 
steady state. Due to the selective upregulation of ABC-G4 transporters caused by 
24OHCh, it is possible that ABC-G4 mediates its efflux (Abildayeva et al., 2006). In 
addition, 24OHCh increases the apoA-I mediated Ch efflux from neuronal cells, 
which may be indicative of an additional clearance pathway (Abildayeva et al., 2006). 
Besides the 24OHCh excretion pathway, other clearance mechanisms may account 
for the excretion of at least 0.5mg Ch/day. The mechanism, although not yet 
completely understood, seems to regulate the excretion of Ch via a coupled ABC-
apoE transport system. ABC-A1 transporters may excrete Ch, which is uptaken by 
apoE-containing lipoproteins to formation of immature, poorly lipidated particles. In 
further maturation steps, Ch may be released from ABC-G1 transporters leading to a 
mature fully loaded lipoprotein. Finally, these particles may be presumably mobilized 
directly across the BBB for excretion to the circulating plasma (Dietschy, 2009).  
 
Regulatory elements of cholesterol synthesis 
 
Liver X Receptors 
Liver X Receptors (LXRs) have been shown to play a central role in the regulation of 
Ch metabolism (Joseph et al., 2002). Two isoforms have been identified in the CNS, 
namely LXRα and LXRβ, the oxysterols being their natural ligands and activators 
(Whitney et al., 2002; Russell et al., 2009). In vitro studies showed that 24OHCh, 
which is thought to mediate its action through LXRs (Abildayeva et al., 2006), induces 
expression of ABC-A1, ABC-G1 and apoE in astrocytic cells, primary rat and murine 
astrocytes, and elevates apoE-mediated Ch efflux (Abildayeva et al., 2006). Indeed, 
ABC-A1, ABC-G1 and ABC-G4 have been identified as LXRs target genes in the 
brain (Tontonoz and Mangelsdorf, 2003; Yu et al., 2003). In mouse brain, deletion of 
LXRα and LXRβ function leads to diminished expression of a number of LXR target 
genes (Wang et al., 2002) while administration of LXR agonists enhances the 
expression of genes controlling the synthesis of ABC-A1, ABC-G1 and apoD (Repa et 
al., 2007) although not clear for apoE (Whitney et al., 2002). Alterations in LXRα/β 
function may lead to a variety of CNS defects upon aging such as lipid accumulation, 
astrocyte proliferation, and disorganized myelin sheets, as shown in LXRα/β null mice 
(Wang et al., 2002). 
Introduction 
5 
Sterol Regulatory Element Binding Protein (SREBPs) 
The Sterol Regulatory Element Binding Proteins (SREBPs) are transcription factors 
that bind to sterol regulatory factors. A number of isoforms have been described, the 
SREBP-2 isoform being involved in the regulation of genes implicated in Ch 
metabolism preferentially. In the Golgi apparatus, proteolytic cleavage of the ~120 
kDa SREBP precursor protein bound to the Ch sensing protein scap (forming 
SREBP-scap complex) releases a transcriptionally active N-terminal fragment (NTF) 
and allows it to move to the nucleus through the cytoplasm. Once in the nucleus, the 
active domain binds to specific DNA sequences (the sterol regulatory elements or 
SREs) leading to a transient increase in the transcription of the target genes 
responsible for the expression of enzymes involved in the synthesis of Ch (Gasic, 
1994; Wang et al., 1994). These nuclear fragments normally drive the expression of 
many of the enzymes required for cholesterogenesis, including 3-hydroxy-3-
methylglutaryl-coenzyme A (HMG-CoA) reductase (Dietschy, 2009).  
In vitro studies shown a transient down-regulation of SREBP-, LDLR and HMG-CoA 
reductase mRNA levels in astrocytoma but not neuroblastoma cell lines upon 
incubation with 24OHCh (Abildayeva et al., 2006). It is long since known that 
oxysterols reduce the activity of HMG-CoA reductase and are more potent inhibitors 
of Ch synthesis than Ch itself (Kandutsch and Chen, 1974). However, the 
mechanisms by which Ch and oxysterols reduce Ch synthesis differ (Adams et al., 
2004). 24OHCh seems to downregulate the mechanisms responsible for Ch synthesis 
(namely SREBPs, LDLR and HMG-CoA reductase) while upregulating the synthesis 
of proteins responsible for Ch efflux and transport between astrocytes and neurons 
(namely ABC-A1, G1 and G4 as well as apoE and apoA-I transporters).  
 
SULFATIDES 
 
Function, synthesis and distribution 
Glycosphingolipids are important components of the outer leaflet of plasma 
membranes; their structures contain carbohydrate moieties believed to be involved in 
important cellular mechanisms such as intercellular recognition, transmembrane 
signal transduction and regulation of cell development and differentiation (Curatolo, 
1987; Hakomori, 1990). The glycosphingolipids galactocerebrosides (GalC) and their 
derived sulfated form, sulfatides, are major lipid constituents of the myelin sheaths 
surrounding axonal processes (Marcus and Popko, 2002) and play an important role 
in maintaining the proper insulating conditions of the membrane.  
GalC and ST bear carbohydrate groups that associate through divalent cation linkages, 
which are believed to provide and stabilize the proper curvature of the myelin 
membrane bilayer (Curatolo, 1987). Furthermore, not only do these glycolipids play a 
role in membrane stability, but they are also believed to participate in the early 
differentiation and myelination process occurring post-natally, suggesting that they are 
necessary for the proper development and maintenance of myelin (Ranscht et al., 
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1982). Furthermore, sulfated glycolipids play essential roles in the plasma membrane of 
cells; ST species contain a negative charge moiety, which facilitates the non-covalent 
binding to any positively charged amino acid side chain at accessible external sites of 
a protein. This type of interaction results in low-affinity binding which will be 
strengthened if the protein has additional binding site domains. Concentration of ST 
molecules in membrane microdomains may constitute an array of negative charges 
that, after initial recognition via specific receptors, may form close contacts between 
cells, membranes or macromolecules (Vos et al., 1994). Therefore, ST may be 
involved in cell adhesion, close contact between biomembranes, cell fusion and 
endocytosis, among other functions. 
Given the important functions attributed to GalC and ST, special interest has been paid 
to characterizing their biosynthesis. GalC are synthesized by UDP-galactose: ceramide 
galactosyltransferase (CGT), a synthase that catalyzes the transfer of galactose to 
ceramide (Coetzee et al., 1996). The enzyme is mainly expressed by oligodendrocytes 
and myelinated regions of the nervous system. In contrast, ST is synthesized by the 
sulfation of the galactose residue in GalC through the enzymatic activity of the 
enzyme cerebroside sulfotransferase (Vos et al., 1994). ST species are mainly 
synthesized by oligodendrocytes, which also synthesize and maintain myelin sheaths 
in the CNS. A number of ST structures have been identified, which vary in the length 
and number of unsaturations of the fatty-acid chain constituting the ceramide moiety. 
Due to the length of the acyl chains contained in the ceramide moiety, the total length 
of a ST molecule usually spans more than half the width of a regular bilayer. Hence, 
ST molecules are packed within the bilayers (Vos et al., 1994). 
 
Abnormalities associated with alterations in galactocerebrosides 
content 
Galactolipids are molecular determinants of myelin development. Mice lacking CGT, 
which is necessary for the production of GalC and subsequent synthesis of ST, form an 
altered type of myelin sheaths containing glucocerebroside, which although not 
identified in normal myelin, is gathered in altered myelin perhaps in order to 
compensate for the lack of GalC. Although these animals display an apparently normal 
myelin sheath structure, they exhibit severe trembling, mild ataxia, age-dependent 
hindlimb paralysis and extensive vacuolation of the ventral region of the spinal cord, 
consistent with a reduced isolating capacity of the myelin sheath (Bosio et al., 1996; 
Coetzee et al., 1996). Furthermore, these mice display hypomyelinated axonal 
processes and there is a significant increase in the number of unmyelinated axons in 
the CNS (Marcus et al., 2000). 
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Figure 1-1. Speculative mechanism for the transport and recycling of Ch in the CNS. Lower left/upper left: 
Astrocytes synthesize apoE and secrete apoE-containing lipoproteins loaded with Ch and lipids, which are then 
recognized and internalized by specific membrane receptors (LDLR and LRP, among others) via endocytosis 
(coated pit pathway). The internalized lipoprotein is then hydrolyzed and Ch is transferred to the metabolically 
active pool by the action of NPC1. Ch excretion from the neuron is mediated by i) the addition of an OH group by 
the action of 24ChOHSE to produce 24ChOH, which is far more polar than Ch and capable of traversing the 
plasma membrane by itself or by the mediation of ABC-G4, and by ii) excretion via ABC-A1 and ABC-G1 
transporters to form premature apoE-bearing lipoproteins, which will subsequently mature and become fully 
loaded particles. The mechanism of excretion of these apoE-loaded particles is not yet understood, but may 
involve selective crossing of the BBB. Lower right/upper right: in the event of synaptic or neuronal damage 
(indicated by L in a red triangle), lipid debris from degenerating myelin are captured by apoE-containing particles, 
which are secreted by astrocytes and microglia, and reuptaken by these glial cells once loaded (although the role 
of microglia in the reuptake of lipid debris is not yet clarified). Loaded astrocytes may then transport the 
reuptaken lipid storages for further recycling and reuse in other metabolic processes. Apo A-I may assist apoE in 
the reuptake of lipid debris by entering the CNS across the BBB or being perhaps synthesized by local glia. 
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Metachromatic leukodystrophy (MLD), also called Arylsulfatase A deficiency, is a 
lysosomal storage disease characterized by the accumulation of ST in the brain, which 
is caused by a dramatic reduction in the activity of the enzyme Arylsulfatase A 
(Poeppel et al., 2005). ST builds up in the CNS, leading to demyelination and resulting 
in neuromotor co-ordination deficits and regression. A recent study has suggested 
lysosulfatide, a ST species lacking the acyl group, as a central player in the 
pathogenesis of the disease (Blomqvist et al., 2011). MLD-associated 
symptomatology  includes muscle wasting, weakness and  rigidity, developmental 
delays, progressive loss of vision leading to blindness, convulsions, impaired 
swallowing, paralysis, and dementia. The late infantile form is the most common form 
of MLD, accounting for 50 to 60% of all cases, whereas the adult form commonly 
begins after the age of 16 as a psychiatric disorder or progressive dementia. Adult-onset 
MLD progression is slower than the late infantile and juvenile forms, with a protracted 
course of a decade or more. Several treatment options are being investigated and 
include gene therapy, enzyme replacement therapy, substrate reduction therapy, and 
potentially enzyme enhancement therapy. However, at the present moment, there is 
neither cure nor standard treatment for MLD. 
Abnormal sulfatide metabolism and homeostasis have been found in association with 
multiple other diseases, such as cardiovascular diseases (Hu et al., 2007) and 
colorectal adenocarcinoma (Morichika et al., 1996).  
 
ALZHEIMER’S DISEASE: THE LIPID CONNECTION 
Background information on Alzheimer’s disease 
Alzheimer’s disease is the most common form of dementia, affecting up to 15 million 
individuals worldwide. By 2050, approximately the 25% of people living in the 
Western hemisphere will be over 65 years of age, and one third of them are likely to 
develop AD (Puglielli et al., 2003). AD is characterised by loss of neurons and 
synapses in the cerebral cortex and certain subcortical regions. This loss results in 
gross atrophy of the affected regions, including degeneration in the temporal and 
parietal lobes, and parts of the frontal cortex and cingulate gyrus (Wenk, 2003). 
Research in the field has been dramatically increasing in recent years, due to the 
global aging of the population and the increasing health costs. Efforts are gradually 
being focused on finding alternative theories to the amyloid-beta (Aβ) cascade 
hypothesis and treatments not involving the removal of Aβ plaques. Increasing 
evidence supports the involvement of Ch in the pathogenesis of the disease (Puglielli 
et al., 2003; Sambamurti et al., 2004; Hirsch-Reinshagen et al., 2009). However, the 
role of lipids during AD progression, especially at early stages, has yet not been 
understood. The following sections present an extensive discussion of some of the 
pathogenic mechanisms underlying AD as well as the implication of Ch and ST in the 
pathogenesis of the disease. 
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The amyloidogenic cascade 
The amyloid precursor protein (APP) is an integral membrane protein with a single 
membrane-spanning domain that presents different isoforms ranging from 695 to 770 
amino acids, the APP695 being the most abundant isoform in the brain. The role of APP 
has not been yet completely understood, but it is mainly synthesized by neurons and 
may contribute to maintain neuronal plasticity and normal synaptic activity. APP is the 
substrate of three basic enzymatic pathways involving α-, β- and γ-secretases; Cleavage 
of APP by α-secretase produces (s)APPα at the cell surface and leaves an 83 amino 
acid carboxy-terminal fragment (CFT) (C83). The amyloidogenic processing of APP 
involves then sequential cleavages by β-secretase (also called β-site APP cleavage 
enzyme, or BACE) and γ-secretase at the N and C terminal sides of the Aβ domain, 
respectively. Concretely, cleavage of APP at the BACE site will leave a 99-amino-acid 
CFT which can be subsequently internalized and processed by γ-secretase to produce 
Aβ1-40/42 in endocytic compartments (Mattson, 2004). γ-secretase is a multicomplex 
enzyme composed of four subunits (presenilin, nicastrin, APH-1 and PEN-2); 
mutations in the presenilin subunits lead to alteration in enzyme activity and are 
associated with familial forms of AD (Haass and De Strooper, 1999). It is to note that 
APP is only one of several proteins uptaken and processed by γ-secretase, with Notch-1 
being another well-studied γ-secretase substrate (Hardy, 1997).  Aβ1-40 and Aβ1-42 are 
the main Aβ peptides synthesized during the amyloidogenic processing of APP; Aβ1-42 
includes two extra hydrophobic residues (isoleucine and alanine) in the sequence, as 
compared to the more abundantly generated Aβ1-40 peptide. Interestingly, the Aβ 42/40 
ratio is increased in familial cases as well as in sporadic AD patients. Figure 1-2 
displays a schematic representation of the amyloidogenic processing of APP described 
above. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-2. Schematic representation 
on the amyloidogenic processing of 
the APP protein in the plasma 
membrane system of neurons. The 
transmembrane APP protein is 
cleaved by α and β secretases to 
produce the extracellular NTFs 
(s)APP α and (s)APP β. Alternative 
cleavage by γ-secretase releases the an 
83 amino acid CTF (C83). After β-
secretase cleavage, further processing 
of the remaining transmembrane 
domain by the γ-secretase complex 
releases Aβ1-40 and Aβ1-42 to the 
extracellular milieu. The remaining 99 
amino-acid CTF (C99) is either 
released and mobilized to the nucleus 
or cleaved by caspases to release a 31 
amino-acid CTF (C31). The 
amyloidogenic processing of APP can 
partially occur in cellular 
compartments, such as endosomes, 
leading to intracellular release of Aβ 
species and CTFs. Figure adapted 
from Mattson et al (2005) with 
permission of Nature Publishing 
Group.  
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Aβ is a naturally occurring peptide in brain and cerebrospinal fluid of healthy humans 
through life (Haass et al., 1992; Walsh et al., 2000). Aβ per se does not cause 
neurodegeneration; neuronal injury seems to require the prolonged self-association of 
Aβ units (Pike et al., 1991). Apparently, long term Aβ overproduction leads to peptide 
aggregation, fibrillation and subsequent formation of extracellular insoluble Aβ 
deposits. Affected regions display two types of plaques; mature neuritic plaques and 
diffuse deposits. Neuritic plaques contain skeins of insoluble amyloid fibrils, 
intermixed with an array of non-fibrillar forms of the peptide. These deposits contain 
both Aβ1-40,  Aβ1-42 and a number of N-terminal truncated peptides (Iwatsubo et al., 
1994) and are surrounded by dystrophic neurites and immunoreactive astrocytes and 
microglia (Selkoe, 2011). In contrast, diffuse deposits are mostly non fibrillar, granular 
structures lacking the surrounding dystrophic neurites and immunoreactive glia. These 
structures are mostly composed of the highly amyloidogenic Aβ1-42 (Iwatsubo et al., 
1994) and are likely to transform into fibril-containing classic senile plaques upon 
maturation (Selkoe, 1994). As these diffuse forms begin to acquire fibrils, local gliosis 
occur, followed by spine loss and dystrophic neurites (Haass and Selkoe, 2007). 
Extracellular deposits have been associated with increased oxidative stress and 
deregulation of Ca2
+
 homeostasis (Mattson, 2004). However, AD progression and 
dementia correlate poorly with brain plaque load (Dickson, 1997) and the role of 
extracellular deposits as an active cause of dementia is under discussion. Indeed, older 
humans have substantial amounts of diffuse Aβ deposits in their limbic cortices and 
still remain healthy (Haass and Selkoe, 2007).  
Aβ in AD brain, however does not only exist as extracellular deposits; Aβ forms a large 
number of complex mixtures that excert a wide spectrum of deleterious effects, and 
include aggregated, fibrillar and the so-called oligomeric Aβ units. Oligomeric Aβ 
species comprise a wide range of structures arising from the assembly of Aβ peptide 
monomer subunits. Although the precise molecular identity of these structures is not 
yet completely understood, it seems that they are not fibrillary in nature (Walsh and 
Selkoe, 2007). Oligomers tend to polymerize and form aggregates; in fact, the 
formation of stable low molecular weight oligomers is a relatively unfavoured process 
(Walsh et al., 1997; Walsh and Selkoe, 2007). Evidence suggests that intraneuronal 
accumulation of oligomeric Aβ1-42 species precedes plaque deposition and may 
contribute to the AD-related cascade of neurodegenerative events (Gimenez-Llort et al., 
2007). Soluble low-n oligomeric species are potent synaptotoxins; intracellular 
accumulation of oligomeric species, either via membrane-mediated internalization or 
intracellular compartmented production, has been associated with synaptic 
dysfunction and neurodegeneration (Haass and Selkoe, 2007); inhibition of 
hippocampal long term potentiation (Walsh et al., 2002); inhibition of the cellular 
proteasome (Tseng et al., 2008) and alteration of the intracellular signaling 
mechanisms, calcium regulation and organelle function (Mattson, 2004; Tseng et al., 
2004). It seems that intraneuronal Aβ excretion is mediated by the ability of synaptic 
activity to clear Aβ from somas and synapses (Tampellini et al., 2011). Cultured 
neurons from a mouse model of AD displayed reduced Aβ1-42 excretion upon time as 
compared to wild-type (WT) control, and early intraneuronal Aβ1-42 accumulation and 
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fibrillization has been observed within cell bodies, neurites, and synapses in a mouse 
model of AD, prior to plaque formation (Capetillo-Zarate et al., 2011). Hence, plaque 
deposition may be the result of a mechanism aiming at excreting the toxic oligomeric 
Aβ units from neuronal somas and synapses rather than an actual critical disease 
hallmark. Figure 1-3 displays a speculative scheme on the interrelation between 
oligomeric Aβ and senile plaques in AD. 
Formation of tau aggregates is another typical protein-associated lesion in AD. Tau is a 
microtubule-associated protein, particularly abundant in the axons of neurons. The 
primary function of tau is to stabilize microtubules (MTs) for an optimal axonal 
transport. During AD progression, the binding of tau to the MTs is perturbed, 
probably due to deregulation of tau kinases and/or phosphatases, mutations of the tau 
gene, and covalent modification of tau causing and/or promoting misfolding (such as 
phosphorylation) (Ballatore et al., 2007). Tau detachment from MTs leads to 
increased cytosolic protein levels, which in turn facilitates protein misfolding and 
subsequent formation of aggregated forms of the protein, such as neurofibrillary 
tangles (NFTs) that accumulate in the cytoplasm of degenerating neurons. Evidence 
suggests that hyperphosphorylated tau is the main component of the NFTs (Busciglio 
et al., 1995), but the cause of such aberrant tau hyperphosphorylation is currently not 
yet understood. NFTs sequester normal MT-associated tau, leading to massive MT 
disruption and impaired axonal transport, which in turn causes synaptic dysfunction 
and neurodegeneration (Ballatore et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-3. Speculative model on Aβ 
fibrillogenesis. (a): fibrillogenesis 
seems to start with the  production of 
seeding nucleus constituted by the 
addition of monomeric Aβ species (1).  
Further addition of monomeric 
species to these nucleated units gives 
rise to protrofibrillar structures (2) 
which in turn may lead to production 
of mature Aβ fibers (3).  
(b): protrofibrillar structures may 
aggregate to form dimers, which in 
turn may act as nucleating units and 
incorporate single monomers or 
protrofibrillar species, giving rise to 
formation of fibrillar structures.  
(c): alternatively, protrofibrils alone 
may be incapable of forming fibers 
but may serve as bioavailable sources 
of monomeric Aβ species, which in 
turn may act as precursors in 
fibrillogenic pathways. Note that the 
different Aβ species are not drawn in 
scale. Reproduced from Walsch et al 
(1997) with permission of the 
American Society for Biochemistry 
and Molecular Biology. 
Santiago Solé-Domènech  
12 
Even though Aβ seems to precede tau pathology in the context of AD progression, the 
connection between oligomeric, fibrillary and deposited forms of Aβ with 
hyperphosphorylated tau and NFT formation is unclear. In fact, the two pathologies 
can occur independently in humans; NFT composed of aggregated 
hyperphosphorylated tau are similar to other tau-associated deposits described in 
several neurodegenerative diseases, such as frontotemporal dementia, in which 
neither Aβ deposits nor neuritic plaques can be found (Selkoe, 2011). Similarly, 
diffuse Aβ deposits can be seen in aged healthy cortex in absence of tangles. 
Nevertheless, Aβ fibrils have been shown to promote tau hyperphosphorylation and 
further MT detachment by increasing kinase activity in a mechanism mediated by 
nicotinic receptors (Wang et al., 2003). The culmination of the amyloidogenic cascade 
involves widespread synaptic and neuronal dysfunction followed by cell death, 
leading to progressive dementia associated with extensive Aβ and tau pathology.  
 
Cholesterol and Alzheimer’s disease 
 
Epidemiological studies 
A number of epidemiological studies suggest that high Ch levels are associated with 
increased risk for AD. Indeed, AD patients show increased levels of total serum and 
LDL Ch together with reduced levels of apoA/ HDL in plasma (Kuo et al., 1998), as 
compared to age-matched controls. Epidemiological evidence suggests that reduction 
of Ch levels by administration of Ch synthesis inhibitors reduces AD prevalence 
(Vance et al., 2005). Statins are drugs that inhibit Ch synthesis and are widely used 
for treatment of hypercholesterolemia, and are currently being actively considered for 
treatment of AD. However, the data on the effectiveness of statin treatment in AD is 
somewhat contradictory; two retrospective epidemiological studies have shown that 
the use of statins in the treatment of hypercholesterolemia reduced the risk of AD by 
40 to 70% (Jick et al., 2000; Wolozin et al., 2000), whereas two other similar 
investigations failed to show a beneficial effect of statins for treatment of AD (2002; 
Shepherd et al., 2002). It is to note that, since the latter studies focused primarily on 
cardiovascular disease, the potential beneficial effects of statins in the treatment of 
AD need to be further evaluated (Casserly and Topol, 2004; Wolozin, 2004). 
Additional studies are required to determine whether statins delay the onset of 
dementia and/or decrease the risk of developing AD as well as the biological 
mechanisms behind such effects. So far, statins have been shown to enhanced Ch 
efflux, upregulate of ABC-A1 and ABC-G1 expression and impair Ch synthesis in 
macrophages (Argmann et al., 2005) In addition, statins reduced plasma levels of 
24OHCh in AD patients without lowering apoE levels (Vega et al., 2003). 
ApoE4 isoform has been identified as a major risk factor for AD in several 
independent epidemiological studies (Tanzi and Bertram, 2001), suggesting a link 
between Ch homeostasis and AD. As previously discussed, apoE is a major 
component of lipoproteins responsible for transporting of Ch in the CNS. Three 
different apoE alleles have been so far identified in humans, namely apoE2, E3 and 
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E4. These alleles produce protein isoforms that differ in certain amino acids at 
specific positions (Puglielli et al., 2003). It has been hypothesized that apoE may 
affect the pathogenesis of AD by isoform-specific effects on lipid trafficking between 
astrocytes and neurons (Michikawa et al., 2000). Individuals carrying the apoE4 
isoform have shown a poor prognosis for recovery of neurological function after head 
trauma (Masliah et al., 1995; Jordan et al., 1997), suggesting that apoE may play an 
important role in Ch recycling and redistribution upon CNS injury. 
 
Underlying molecular mechanisms 
During recent years, a number of investigations showed increased Aβ deposition 
(Sambamurti et al., 2004), increased immunoreactivity (Sparks et al., 1995) and tau 
hyperphosphorylation (Rahman et al., 2005) in different animal models of AD fed 
with high Ch diets. However, the molecular mechanisms underlying the Ch-AD 
connection remain enigmatic. Studies in cell lines have shown that Ch can actively 
regulate APP processing and Aβ generation. Ch-enriched microdomains in the plasma 
membrane of neurons display an increased amyloidogenic processing of APP 
(Ehehalt et al., 2003). Concretely, the neuronal membrane system seems to distribute 
APP into two differentiated pools, namely i)APP associated with Ch-rich lipid rafts 
clusters which seems to undergo BACE cleavage, and ii) APP outside lipid rafts, 
which undergoes α-secretase cleavage. Hence, increased Ch levels in the plasma 
membrane of neurons (and even glia) may trigger the amyloidogenic processing of 
APP by increasing the fraction of protein colocalized with BACE.  
Furthermore, it has been shown that intracellular Ch distribution modulates APP 
processing and Aβ generation. Cellular Ch is stored either as UCh in the plasma 
membranes or as ECh in lipid droplets; the action of acyl-coenzyme A cholesterol 
acyltransferase (ACAT) controls the equilibrium between these two forms of cellular 
Ch and maintains Ch homeostasis. It has been suggested that this dynamic 
equilibrium ultimately regulates the generation of Aβ (Puglielli et al., 2001). That is, 
an increase in ECh is sufficient to up-regulate Aβ generation and increase the 
production of β-APP CFTs. Consistently, ACAT inhibitors reduced both ECh and Aβ 
synthesis, while increasing UCh levels (Puglielli et al., 2001). ACAT inhibitors have 
been suggested as suitable drugs in the treatment of AD; an increase in the cytosolic 
levels of UCh, however, may potentially induce cytotoxic events. 
In fact, the function of several important enzymes controlling Ch homeostasis may be 
altered in AD. For instance, the levels of lecithin cholesterol acyltransferase (LCAT), 
an enzyme found in plasma, are significantly reduced in AD patients (Knebl et al., 
1994). The enzyme plays a central role in the reverse Ch transport, which eliminates 
Ch from peripheral cells. LCAT converts UCh into ECh, which is then transferred to 
lipoprotein particles and mobilized. Reduced LCAT activity leads to increased Ch 
plasma levels, increased LDL-associated Ch (leading to Ch accumulation in tissues) 
and reduced HDL-Ch (responsible for transporting Ch to the liver for further 
excretion) (Puglielli et al., 2003).  
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The transport of Ch and other lipids may directly or indirectly control the Ch-
induced Aβ production. The role of apoE in maintaining brain Ch homeostasis may 
contribute to the increased risk for AD associated with apoE4. For instance, apoE 
may alter brain Ch homeostasis by modifying lipoprotein-particle formation; apoE4 
tends to associate with VLDL particles, which contain more Ch, whereas apoE3 binds 
to HDL particles. Indeed, subjects homozygous for apoE4 allele show higher levels of 
Ch in plasma (Ehnholm et al., 1986) and 24OHCh in cerebrospinal fluid (CSF) 
(Papassotiropoulos et al., 2002). However, apoE4 has shown reduced Ch transport 
capacity as compared with the other alleles (Elliott et al., 2010). Besides, several 
studies have shown that apoE can bind to Aβ (Näslund et al., 1995) and facilitate its 
aggregation in an isoform-dependent manner E2>E3>E4 (LaDu et al., 1994). apoE 
may mediate Aβ toxicity by internalization through LDLRs, in a process mediated by 
LRPs (LaDu et al., 1994; Chung et al., 1999) which are mainly expressed in neurons 
and activated astrocytes (Bu et al., 1994) whereas LDLRs are expressed mainly in 
glia (Pitas et al., 1987). LRP1 conditional knockout (KO) mice display increased 
cerebral apoE levels and a 40% decrease in brain Ch levels, consistent with the 
function of LRP1 as a mediator of apoE uptake in the CNS (Liu et al., 2007).  
 
Sulfatides and Alzheimer’s disease 
The analysis of ST has been traditionally challenging, mainly due to important 
technical limitations. Han and collaborators created an approach called shotgun 
lipidomics (Han and Gross, 2005) consisting in the use of electrospray ionization mass 
spectrometry in the study of complex mixtures of ST and lipids, allowing for qualitative 
and quantitative determination of the levels of number of ST species in tissue. Han and 
collaborators, using their shotgun lipidomics approach, and others investigators, have 
studied the content and distribution of ST in human and animal tissues affected by AD 
pathology. 
A dramatic decrease in ST levels has been observed in post mortem brain tissue from 
AD patients (Svennerholm and Gottfries, 1994; Han et al., 2002), patients with 
incipient dementia and patients with mild cognitive dementia (MCI) (Han et al., 2003b; 
Irizarry, 2003) whereas the levels and activity of the enzymes involved in the synthesis 
of the glycosphingolipid remained apparently unaltered (Cheng et al., 2003). ST 
depletion seems to occur specifically in brain tissue affected by AD, as study of brain 
samples from patients suffering from other neurodegenerative processes did not reveal 
significant variations in ST levels (Cheng et al., 2003).  
Studies in mouse models of AD suggested that ST depletion is mediated by apoE. 
APPswe transgenic (Tg) mice displayed a decrease in ST levels that was age and region 
dependent; ST levels were significantly decreased in cortical structures, but only 
slightly decreased in cerebellum, already at 9 months of age. Surprisingly, the levels of 
other glycosphingolipids (such as GalC) were not altered as compared to WT (Cheng et 
al., 2008). Furthermore, APPswe animals KO for apoE displayed unaltered ST levels as 
compared to age-matched APPswe normally expressing apoE.  
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Furthermore, it has been shown that ST associates preferentially to apoE-containing 
HDL particles, and that apoE presents a ST transport capacity in an E4>E3>E2 fashion 
(Han et al., 2003a). Based on these observations, Han and collaborators suggested a 
mechanism in which nascent apoE-bearing particles, released from astrocytes, approach 
myelinated regions of the neurons and capture ST in a kiss-and-run mechanism. The 
loaded lipoprotein is then either internalized by the neurons through an LDLr 
superfamily membrane receptor (for further degradation) or excreted through the BBB. 
Given the fact that apoE4 exhibits increased ST binding affinity, brain structures in 
apoE4 carriers may undergo accelerated ST loss and myelin alteration, thus increasing 
the risk of developing dementia (in an AD context). However, it is difficult to conceive 
a selective apoE-mediated sequestration of myelin ST, as apoE-bearing lipoproteins 
display very high binding affinity for Ch and no concomitant decrease in Ch levels has 
been observed in mouse or human brain regions affected by ST depletion. Furthermore, 
the excretion of ST-loaded lipoproteins through the BBB must necessarily involve 
crossing the barrier; as discussed previously, such mechanism may exist, but has not 
yet been clarified. 
The fact that ST depletion has been observed in cortical structures but not in cerebellum 
of APPswe animals suggests that ST may be associated with Aβ, as cortical regions 
display much more Aβ load than cerebellum. Consistently, the onset of decreased ST 
matched to that of the underlying Aβ pathology in these animals. Furthermore, poorly 
myelinated regions seem to be more prone to undergo ST depletion, as MCI patients 
displayed a 90% decrease in the levels of grey matter ST, compared to only 50% in 
white matter structures (Han et al., 2002). It has been shown, also by Han and 
collaborators, that ST species present in vesicles bind to Aβ and mediate its clearance 
via an endocytotic pathway. Concretely, ST administered to H4-APPwt cells, which 
secrete large amounts of Aβ into the cell media, reduced Aβ production in a dose-
dependent manner (selectively for Aβ1-42) whereas other anionic lipids did not alter 
media Aβ levels significantly (Zeng and Han, 2008). The role presumably played by 
ST in the clearance of Aβ species is consistent with the selective vulnerability of 
cortical regions to Aβ pathology; the decrease in cortical levels of ST may reduce Aβ 
clearance rate in these regions, boosting the amyloidogenic cascade and leading to 
increased Aβ levels and subsequent senile plaque deposition. 
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LIPID IMAGING TECHNIQUES 
Given the tight association between lipids and neuropathology, it is necessary to 
develop tools allowing for the detailed molecular imaging of lipids and lipid precursors 
in human and animal brain tissue samples. Fluorescence techniques such as selective 
lipid stains are capable of imaging the distribution of lipids using confocal microscopy 
with great lateral and axial resolution. Furthermore, mass spectrometric imaging 
techniques offer the possibility to simultaneously image a wide range of analytes in a 
particular sample. The different techniques differ in terms of specificity, sensitivity and 
resolution, each technique being appropriate for each particular analytical problem. The 
following section will discuss lipid imaging methods with special attention being paid 
to Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) imaging. 
 
Cholesterol imaging by fluorescent techniques 
A number of commercially available fluorescent assays offer the possibility to image 
Ch in cells and biological tissue samples. Filipin was developed in the late 1950s as an 
antibiotic compound with potent antifungal activity (Whitfield et al., 1955). In cellular 
biology, Filipin is used as an inhibitor of the raft/caveolae endocytosis pathway on 
mammalian cells, but most importantly, the dye binds to cellular Ch and related sterols 
with high affinity. The currently available Filipin dye is a mixture of four different 
complexes (namely Filipin I, II, III and IV) and is especially suited for binding and 
imaging of cellular UCh. However, the dye undergoes rapid photobleaching, and 
exhibits modest fluorescence under UV excitation, thus hampering imaging using 
confocal microscopy and limiting its application in cell biology and tissue imaging. 
Cholesterol can also be imaged using a colorimetric method based on the selective 
oxidation of Ch by Ch-oxidase, which produces H2O2 that, in turn, oxidizes 10-acetyl-
3.7 dihydroxyphenoxazine (Amplex Red) into the highly fluorescent compound 
resorufin, in the presence of horseradish peroxidase (HRP). The compound can then 
be imaged using fluorescence microscopy. However, a recent study suggests that 
Amplex Red may exhibit significant autofluorescence depending on the oxidative 
status of the biological sample being imaged. For instance, senile plaques treated with 
the colorimetric assay have been shown to emit fluorescence even in the absence of 
Ch-oxidase (Lebouvier et al., 2009), which could be partially due to the Ch-oxidase-
like activity presented by senile plaques (Puglielli et al., 2005). 
A new Ch binding agent, BCθ, has been shown to bind to UCh in cells and biological 
tissue with high affinity. BCθ originates from a toxin produced by Clostridium 
perfringens. For imaging purposes, the toxin has been biotinylated, allowing for 
subsequent imaging of BCθ bound to Ch-enriched domains using avidin-conjugated 
fluorescent indicators. The assay presents robust fluorescent properties and can be 
optimally imaged using fluorescence microscopy in a manner superior to that of 
Filipin (Reid et al., 2004).  
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TIME-OF-FLIGHT SECONDARY ION MASS SPECTROMETRY 
 
The following section includes a brief historical perspective on the application of SIMS 
and ToF-SIMS to the analysis of biological samples. The reader is asked to refer to the 
last section, entitled Background information on secondary ion mass spectrometry 
(SIMS) in order to understand the physical and chemical principles underlying the 
methodology. 
 
Broad perspective on the analysis of biological samples using ToF-SIMS 
The first steps in the analysis of biological preparations were given by Benninghoven in 
the late 70s. At that time, prior to the introduction of cluster ion sources and Time-of-
Flight (ToF) detectors, the analysis of  biological substances was primarily performed 
using monoatomic primary ions (Benninghoven et al., 1976)  In 1978, Benninghoven 
et al. used an Ar
+
 ion source to study more than 40 biologically relevant compounds, 
including amino acids, peptides, drugs, vitamins, and pharmaceuticals (Benninghoven 
and Sichtermann, 1978). Emission of highly specific secondary ions was observed 
from these compounds, such as molecular ions and smaller characteristic fragment 
ions.  
At the beginning of the 80s, Chait and Standing reported significant improvements in 
the mass resolution and transmission efficiency of SIMS by implementing the ToF 
analyzers for SIMS analysis of biological compounds (Chait and Standing, 1981).  In 
1986, Jabs et al. used ToF-SIMS, also equipped with Ar
+
 primary ions, to investigate 
structural differences among apolipoprotein isoforms. In their work, spectral analysis 
allowed for structural differentiation of two apolipoprotein mutants (Jabs et al., 1986). 
Some more work dealing with the structural determination of apolipoproteins 
followed (Voneckardstein et al., 1989; Voneckardstein et al., 1990). At that stage, 
some of the currently known advantages of ToF-SIMS were revealed, such as the 
high accuracy of molecular weight determination (±1 Da) within a mass range up to 
3000 Da, the small amount of sample required for the analyses and the associated 
easy handling and preparation of samples. 
Besides the introduction of ToF analyzers, the implementation of the currently used 
cluster ion sources facilitated a significant improvement in the analysis of not only 
peptide and protein preparations but also of biological tissue material, providing 
enhanced secondary ion yields and detection efficiencies for large characteristic 
secondary ions (Kollmer, 2004). Studies on biological peptides and tissues benefited 
from such technical improvements; Touboul et al. reported the analysis of several 
biological peptides as well as of mouse brain tissue sections using polyatomic Au3
+
 
ions (Touboul et al., 2004), achieving high sensitivity and high lateral resolution with 
low primary ion doses and without any tissue pretreatment or matrix deposition. 
Furthermore, Sjövall et al. reported the detailed study of Ch, ST, 
phosphatidylinositols (PI) and phosphatidylcholines (PC) in mouse brain structures, 
also using Au3
+
 primary ions (Sjövall et al., 2004). In their work, principal component 
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analysis of spectra recorded at different regions of the tissue allowed for identification 
of common spectral fingerprints, and revealed large variations in the lipid 
composition among several brain structures. 
Important work involving biological tissue followed; Touboul et al. studied the lipid 
profile of tissue affected by Duchenne muscular dystrophy, allowing for 
discrimination between tissue regions affected by different degrees of pathogenic 
progression (Touboul et al., 2005), and Brulet et al. studied colon tissue sections of a 
mouse model of cystic fibrosis, showing a significant increase in vitamin E and C16:0 
fatty acid in the epithelial border of the colon, together with localization of specific 
lipid compounds in several other tissue structures (Brulet et al., 2010). Furthermore, 
Seedorf et al. used ToF-SIMS to diagnose Smith-Lemli-Opitz syndrome, an 
autosomal recessive metabolic and developmental congenital disorder that causes the 
inability to synthesize Ch due to a low occurrence of the 7-dehydrocholesterol (7DHC) 
reductase enzyme, leading to accumulation of the Ch precursor in tissues (Seedorf et 
al., 1995).  Only minute amounts of blood, analyzed with ToF-SIMS, were necessary 
to perform the diagnosis, revealing increased 7DHC levels in patients, as compared to 
controls. It is to note that the work involving ToF-SIMS imaging of lipids in 
biological tissue is considerably extensive, and has been reviewed in detail elsewhere 
(Brunelle et al., 2005; Passarelli and Winograd, 2011).  
In parallel, the study of cells and cell membranes using ToF-SIMS received 
considerable attention; Ostrowski et al. used ToF-SIMS to study the lipid content of 
cellular membranes involved in fusion processes, revealing differences in high and 
low-curvature lipids in regions involved in the fusion process (Ostrowski et al., 
2004). Furthermore, Ostrowski et al. used ToF-SIMS to comparatively quantify the 
difference in Ch levels in the plasma membranes of two cells, which allowed for 
discrimination of two macrophage populations treated to contain different cellular 
levels of Ch (Ostrowski et al., 2007). Although similar work followed, the use of 
ToF-SIMS in cell biology is limited, partly due to analytical problems related to 
sample preparation and data interpretation (Walker, 2008). Nevertheless, important 
efforts are being focused on optimizing sample preparation and analysis conditions 
(Malm et al., 2009).   
At the current stage, the use of ToF-SIMS in the study of biological and medical 
paradigms is still under development, and mainly descriptive work has been reported. 
Given the increasing evidence supporting the involvement of lipids in several 
neurodegenerative diseases such as Niemann-Pick or AD, techniques allowing for 
imaging and quantification of lipids and lipid precursors in biological tissues are 
gaining growing attention. ToF-SIMS and other mass spectrometry imaging (MSI) 
techniques, capable of providing detailed insight of the content and distribution of 
lipids in tissues, might be of great use in the study of lipid-related disorders. 
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Background information on Secondary Ion Mass Spectrometry (SIMS) 
Secondary ion mass spectrometry (SIMS) is a surface analysis technique that provides 
detailed information on the atomic and molecular composition of the uppermost 
monolayer of a solid (Benninghoven, 1975, 1994). In SIMS, the ionization process 
involves the use of primary ions that, upon impacting the sample surface, cause 
ejection of secondary (analyte) ions, which are further mobilized and processed by a 
detector to generate mass spectra from the scanned areas. Each secondary ion, 
belonging to a specific analyte or compound in the sample surface, will display a 
distinct peak in the spectrum, with variable intensity depending on its mass and 
chemical characteristics. Figure 1-4 displays a schematic representation of the 
ionization process underlying SIMS. 
The primary ion beam originates from a source or metal gun that emits primary ions.  
Initial SIMS spectrometers were equipped with ionization sources that emitted 
monoatomic primary ions, such as Ar
+
 or Cs
+
. However, the use of monoatomic 
primary ions in the study of biological samples is limited, as they provide low 
secondary ion efficiencies and cause extensive analyte fragmentation. The 
introduction of polyatomic cluster ions, such as Au3
+
, Bi3
+
 or C60
+
 reduced analyte 
fragmentation and improved the secondary ion yields of larger molecules such as 
lipids. Generally, the efficiency of a particular primary ion is improved with the mass 
of the monoatomic primary ion, and a further increase is obtained by the use of 
polyatomic primary ions (Kollmer, 2004).  
ToF-SIMS allows for imaging of the scanned areas. During analysis, the primary ion 
beam is swept over the analysis area, causing desorption of analyte secondary ions, 
which are then collected and analyzed to generate separate mass spectra. The 
recorded data is then used to produce ion images from the areas scanned, showing the 
signal intensity distribution over the analysis area of selected secondary ion peaks 
representing specific compounds. That is; after data acquisition, ToF-SIMS software 
allows for generation of images by selecting and integrating a particular peak 
representing a specific secondary ion (i.e. cholesterol or sulfatides).  
The lateral resolution in ToF-SIMS and other MSI techniques is determined by the 
focus diameter of the ionization beam. In ToF-SIMS, the reduced diameter of the 
primary ion beam allows for acquisition of images with great lateral resolution; the 
instrument operates either optimized for high mass resolution (bunched mode, mass 
resolution m/Δm ≈ 5000, lateral resolution 3-5 μm) or for high image resolution 
(burst alignment mode, mass resolution m/Δm ≈ 300, lateral resolution <500 nm). 
Remarkably, in some cases the instrument has been capable of imaging with lateral 
resolutions down to ~100nm provided that certain experimental conditions were 
given (Touboul et al., 2011). Our studies dealing with the distribution of Ch and other 
lipid structures in mouse and human brain tissue provided images acquired with great 
lateral resolution (<500 nm); cell nuclei displayed by CN
-
 and CNO
-
 ion patterns 
were resolved at ~15-25 μm, whereas the smallest detected Ch deposit was resolved 
at ~2 μm.  
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The implementation of ToF detectors, cluster ion sources and other technological 
improvements that allowed for the study of biological samples with reduced analyte 
fragmentation and increased efficiencies lead to the modern “ToF-SIMS imaging” 
concept presented in this thesis work. The current sensitivity and resolution are 
sufficient for cellular imaging of many lipids of likely pathophysiological importance. 
 
Other mass spectrometry imaging techniques relevant to biological 
tissue imaging 
Imaging of biological tissue samples has been broadly approached by the mass 
spectrometry community. A number of different instruments have been used in the 
analysis of biological tissue, with variable results. In MSI, the ionization source is an 
energetic photon or particle beam that impacts the sample, causing analyte ionization. 
Charged analyte particles are then mobilized and processed into the instrument’s 
detector, to generate mass spectra form the scanned regions. As previously discussed, 
an important feature in MSI is the size of the ionization beam, which determines the 
lateral resolution of the acquired images. Concretely, the size of the ionization beam 
determines the dimensions of the image pixel corresponding to each point scanned, for 
which a mass spectrum has been acquired. Furthermore, a factor likely to restrict the 
information that is acquired from the sample is the fragmentation caused by a particular 
ionization source, which determines the molecular weight of the analyte fragments 
being produced and detected by the instrument. Mass spectrometers equipped with 
ionization sources that induce high analyte fragmentation will produce and detect low 
molecular weight ion fragments. In contrast, instruments inducing softer analyte 
ionization will produce larger analyte fragments, allowing for the study of larger 
compounds such as macromolecules and proteins. 
 
Figure 1-4. Generation of secondary ions in ToF-SIMS 
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Two of the most broadly used MSI techniques are Desorption Electrospray Ionization 
(DESI) and Matrix-Assisted Laser Desorption Ionization (MALDI). DESI can be 
operated at atmospheric pressure, and uses a pneumatically assisted electrospray 
source to desorb analytes from the sample surface. DESI is very sensitive for low 
molecular weight compounds such as lipids and peptides. However, its current lateral 
resolution is limited to 100 mm. MALDI is the most popular MSI method; the 
instrument is equipped with a low UV laser beam as ionization source, and the 
sample is treated with a matrix (of variable composition) that absorbs UV light, 
leading to ablation of the upper layer (1 µm) of the matrix material for subsequent 
ionization and fragmentation of analyte molecules. The method allows for imaging of 
lipids as well as of large ions such as from proteins, with a lateral resolution of ~50 
µm. In these techniques, as compared to ToF-SIMS, the lateral resolution is restricted 
by the large diameter of the focal ionization beam.  
In order to contextualize ToF-SIMS, a brief comparison of these mass spectrometers, 
commonly applied to the analysis of biological samples, has been summarized in Table 
1-1. Mass spectrometers commonly applied to the analysis of biological samples have 
recently been reviewed in detail by Touboul et al. (Touboul et al., 2011).  
 
 
 
  
Table 1-1. Comparison between DESI, MALDI and ToF-SIMS imaging mass spectrometers in the context of 
biological tissue/sample imaging. Adapted from Touboul et al (2011) with permission of Elsevier. 
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AIMS 
 
The general aim of this thesis was to apply ToF-SIMS to the study of biological 
samples. A first, basic optimization of ToF-SIMS protocols relevant to the study of 
tissue sections was followed by application of the developed methodology to the study 
of tissue affected by Alzheimer’s disease pathology. 
 
 
 
I. Investigate the effect of common histological stains and analysis conditions to 
the distribution of lipids and other analytes at the surface of biological tissue 
sections using ToF-SIMS. 
 
 
II. Study of opioid and amyloid–related fingerprints present in ToF-SIMS spectra 
obtained from the analysis of synthetic peptide preparations. 
 
 
III. Develop a methodology combining ToF-SIMS and fluorescence techniques 
allowing for the simultaneous spatial study in biological tissue of lipids and cell 
populations relevant to Alzheimer’s disease, and further determine the spectral 
and visual fingerprints associated with extracellular amyloid-beta deposits. 
 
 
IV. Further use of the imaging methodology developed to study the interaction 
between extracellular amyloid-beta deposits, cholesterol and glial cells in 
biological tissue affected by Alzheimer’s disease pathology. 
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MATERIALS AND METHODS 
 
BIOLOGICAL TISSUE SAMPLES 
 
Mouse tissue 
Experiments were performed in accordance with the relevant guidelines from the 
Swedish National Board for Laboratory Animals, the Spanish legislation on “Protection 
of Animals Used for Experimental and Other Scientific Purposes” and the European 
Communities Council Directive (86/609/EEC Council). Mice were kept under standard 
laboratory conditions of food and water ad libitum, 22 + 2 ºC, a 12 h light: dark cycle 
and relative humidity of 40-60%. Tg2576 and 3xTg-AD animals were 24 and 18 month 
old (± 2 weeks) when sacrificed, respectively. 3xTg-AD mice were euthanized using 
CO2 whereas Tg2576 mice were sacrificed by cervical dislocation. The brains were 
quickly dissected and immediately frozen on dry ice, followed by storage at -80°C.  
Adipose tissue was obtained from 129xC57BL6 hybrid mice. Animals were briefly 
anesthetized with CO2 and decapitated. The gluteal fat pads were collected, 
immediately frozen on dry ice and stored at -80°C. All animals had been previously 
behaviorally tested. Behavioral data is, however, beyond the scope of the current report, 
and will not be presented herein. 
 
3xTg-AD model 
Female 3xTg-AD mice were provided by Dr. Lydia Giménez-Llort (UAB, Spain) from 
her Spanish colony of homozygous mice after Material Transfer Agreement with Dr. 
Frank LaFerla (University of California Irvine, California, USA). The 3xTg-AD mouse 
model (Oddo et al., 2003) bears three human mutant genes; presenilin-1 (PS1) with the 
M146V mutation, the human APP gene with the Swedish mutation, and tau with the 
P301L mutation, the latter two expressed under the control of the Thy 1.2 regulatory 
element. The animals display progressive age-related memory impairment already 
evident at 6 months of age that correlates with intraneuronal Aβ pathology (Gimenez-
Llort et al., 2007). Intracellular Aβ becomes evident at 3-4 months in neocortex, and by 
6 months in CA1 subfield of hippocampus. At 12 months of age, the animals show 
widespread Aβ deposition in cortical regions and hippocampus. Tangle formation 
becomes evident first affecting the CA1 subfield at 12 month of age and later spreading 
to cortical regions, followed by tau reactive dystrophic neurites surrounding globular 
structures in 18 month old animals (Oddo et al., 2003). Age-matched wild-type control 
129xC57BL6 hybrid mice were also provided by Dr. Giménez-Llort. 
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Tg2576 model 
Female Tg2576 mice were purchased from Taconic (Cologne, Germany). The Tg2576 
mouse model (Hsiao et al., 1996) expresses the human APP695 isoform with the 
Swedish double mutation K670N-M671L under control of the hamster PrP promoter. 
Tg2576 animals show impaired learning and memory abilities already at 7 month of 
age, accompanied by dramatic increase in Aβ production. Diffuse focal deposits are 
already present in cortical and limbic structures at 10-12 month of age, together with 
dystrophic neuritis (Balducci and Forloni, 2011). Age-matched wild-type control 
B6SJLF1 mice were also purchased from Taconic. 
 
Human brain tissue 
Human brain samples, provided by Huddinge Biobank (Karolinska Institutet Huddinge, 
Sweden), were handled and stored according to the regional Swedish Ethical Review 
Board guidelines. Temporal lobe blocks were obtained from a female patient (age 65, 
postmortem time 23h) diagnosed with AD Braak stage IV (Braak and Braak, 1991) 
after post-mortem brain study. The tissue presented severe brain atrophy and moderate 
congophilic angiopathy. Temporal lobe blocks from a non-demented female patient 
(age 79, postmortem time 17h), also subjected to post-mortem inspection, did not 
present any signs of AD-related pathology and were included in the study as control 
tissue. Cryosections were prepared and stored as described above. 
 
Synthetic peptide preparations 
Eight different peptides were analyzed with ToF-SIMS; six endogenous opioids and 
two separate fragments of Aβ, listed together with their molecular weights and amino 
acid sequences in Table 2-1. The peptides were provided in pure crystal form by 
Bachem (Bubendorf, Switzerland). Each peptide sample was introduced into a 
sterilized Eppendorf tube and dissolved in Milli-Q water without further purification 
at concentrations given in Table 2-1. The resulting solutions were vortexed several 
minutes to ensure complete dissolution of the peptide. A 5-10 μL drop of the peptide 
solution was deposited onto the surface of a silicon wafer substrate and allowed to dry 
at RT, leaving a peptide deposit coating the surface. The wafers were previously 
cleaned by washing sequentially in heptane, acetone, and ethanol. After preparation, 
the samples were introduced into the vacuum chamber of the ToF-SIMS instrument 
for analysis of the pure peptide deposits. 
 
 
 
 
 
 
Table 2-1. List of peptides analyzed with ToF-SIMS (paper II) 
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TOF-SIMS ANALYSIS 
 
ToF-SIMS instrumentation 
The ToF-SIMS analysis of peptide preparations and biological tissue sections was 
carried out using a ToF-SIMS IV instrument (ION-TOF GmbH, Münster, Germany) 
equipped with a reflectron-type time-of-flight mass spectrometer. Tissue sections were 
analyzed using 25 keV Bi3
+
 primary ions, whereas peptide preparations were analyzed 
using both 25keV Bi3
+ 
and 25keV Au3
+
 primary ions. The data was acquired using low-
energy electron flooding for charge compensation and with the instrument optimized 
for high mass resolution (bunched mode, mass resolution m/Δm ≈ 5000, lateral 
resolution 3-5 μm) or for high image resolution (burst alignment mode, mass resolution 
m/Δm ≈ 300, lateral resolution 200 nm). Here, Δm is the FWHM of a peak in the mass 
spectrum at mass m and the lateral distribution is determined by the focus diameter of 
the primary ion beam. The pulsed primary ion current was 0.1 pA in the bunched mode 
and 0.04 pA in the burst alignment mode when using 25 keV Bi3
+
 primary ions, 
whereas 0.03/0.04 pA intensity was reached when using Au3
+
 primary ions in the 
bunched mode. The accumulated ion dose was always kept below 1x10
12
 ions/cm
2
. 
During analysis, the primary ion beam was scanned over the analysis area, collecting 
separate mass spectra of the emitted secondary ions from 128x128, 256x256 or 
512x512 raster points (pixels). The recorded data were used to produce total area mass 
spectra and/or ion images showing the signal intensity distribution over the analysis 
area of selected secondary ion peaks representing specific compounds. Images 
generated in the analysis of biological tissue samples were normalized to the maximum 
signal intensity in a single pixel. 
 
Spectral analysis 
The increased useful mass range from use of cluster primary ions allows for the 
analysis of biosubstances of higher molecular mass, but masses are thus often 
calculated from flight times by extrapolation. However, interpolation is inherently 
more accurate than extrapolation. This is in agreement with our experience from ToF-
SIMS analysis of biomedical samples. Therefore, calibration of the recorded spectra 
was carried out including the molecular ions as well as some ions at the low mass 
ranges –CH3, C2H2, C3H2, C4H2 for the positive and C, C2, C3, C4H for the negative 
ion spectra–  in order to cover a wide range of masses and allowing the assignment of 
peaks by interpolation. In the peptides study, reliable signals from (M + H)
+
 and (M - 
H)
-
 molecular ions were observed and included in the calibration procedure. 
Assignments were slightly less ambiguous after including the molecular ions in the 
calibration. In the analysis of biological tissue, spectra were calibrated including ions 
in the low mass range and ions related to Ch, namely the peak at 369 u corresponding 
to the de-hydroxylated fragment of Ch, [Ch-OH]
+
, and the peak at 385 u corresponding 
to the deprotonated Ch molecule, [Ch-H]
+
. However, it should be noted that this 
procedure can only be applied when a safe assignment of the molecular peak can be 
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made, such as in the present case. Spectra were analyzed using the standard IonSpec 
software (ION-TOF, Münster, Germany). 
 
Imaging of biological tissue  
 
Preparation of tissue sections 
In ToF-SIMS, the mass spectrometry analysis from a particular region of a biological 
tissue sample is very sensitive to small modifications of the chemical structures in the 
sample. The application of chemical fixatives to the tissues may substantially alter the 
chemical composition and the lateral distribution of the probed analyte ions (Bélazi et 
al., 2009). Therefore, only fresh frozen non-fixed brain tissue was analyzed in this 
work. In order to avoid sample contamination, all surfaces and instruments used during 
cryosectioning of tissues were washed in ethanol and acetone, air dried and pre-cooled 
at -20°C. Furthermore, the use of mounting glue to hold the tissue blocks during 
cryosectioning caused contamination of the tissue sections, which could be recognized 
in the ToF-SIMS spectra and lead to artifacted images. In order to avoid the 
contamination of tissues, mouse brains were hold to the cryostate’s chuck using water, 
which would freeze and hold the brain during sectioning. 
 
Analysis at -80°C  
Sample temperature is another important factor in ToF-SIMS analysis that may affect 
the distribution of lipids in tissue sections. It has been shown that tissues analyzed at 
temperatures above 0°C display altered lipid signals, as compared to samples 
recorded at low temperatures, probably due to diffusion of analytes from within 
interior layers of the tissue (Sjövall et al., 2006). In order to prevent analyte diffusion, 
cryosections were transported and kept at -80°C or below during the entire sample 
preparation and ToF-SIMS analysis procedure. In order to allow for cold analysis, the 
surface of the glass slides holding the particular brain section had to be cut in 1x1 cm 
square areas using a standard glass cutter, and put onto the ToF-SIMS mobile stage 
holder, previously refrigerated in liquid nitrogen. The ToF-SIMS analysis was carried 
out at -80°C by refrigerating the instrument with liquid nitrogen.  
 
Localization and imaging of selected areas  
In order to locate relevant areas for ToF-SIMS analysis, tissue sections adjacent to 
those planned for ToF-SIMS analysis were stained with Pentamer Formyl Thiophene 
Acetic Acid (p-FTAA) amyloidotropic fluorescent dye and BOBO-1 nuclei marker 
(described below) and imaged using confocal laser scanning microscopy (CLSM). 
These CLSM images were then used as navigation-guiding templates during the ToF-
SIMS measurements. The recorded data was then used to produce ion images from 
the areas scanned, showing the signal intensity distribution over the analysis area of 
selected secondary ion peaks representing specific compounds, as described above. 
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FLUORESCENCE TECHNIQUES 
 
p-FTAA staining of senile plaques 
Mouse brain sections analyzed with ToF-SIMS were thereafter incubated with p-
FTAA, an amyloidotropic fluorescent dye (Åslund et al., 2009). Sections were fixed in 
absolute ethanol for 10 min and rehydrated in water followed by PBS. Working 
solution of p-FTAA (1.5 mM) was diluted 1:500 in PBS and added to the brain 
sections, which were then incubated for 30 min at room temperature (RT) and washed 
with PBS. The sections were mounted with Dako mounting solution for fluorescence 
(Dako, Glostrup, Denmark) and kept at 4°C until imaged. 
 
Combined Iba1/GFAP/p-FTAA immunostaining of tissue sections 
Mouse brain sections analyzed with ToF-SIMS (or adjacent sections) were 
immunostained with antibodies against glial fibrillary acidic protein (GFAP) and 
ionized calcium binding adaptor molecule 1 (Iba1) as well as for Aβ (using p-FTAA) 
and nucleic acid (using BOBO-1 cell nuclei marker). Sections were air-dried and post-
fixed in 4% PFA for 1 hour at RT. Treatment in 0,3% H2O2 followed (10 min RT) to 
block endogenous peroxidase activity. Sections were then treated with blocking 
solution (5% normal goat serum, 2% bovine serum albumin and 0,3% Triton-X100 in 
PBS) at RT for 2h and thereafter incubated with rabbit polyclonal anti-Iba1 IgG 
antibody (1:200, Wako, Osaka, Japan) in diluted blocking solution at 4°C for 13 days. 
Iba1 was detected with an Alexa 633 goat anti-rabbit IgG secondary antibody (1:800, 
Invitrogen Life Technologies, Stockholm, Sweden) in diluted blocking solution at RT 
for 1h. An additional 10 min post-fixation step in 4% PFA was performed afterwards, 
in order to reinforce the primary-secondary antibody binding. Next, sections were 
incubated in rat monoclonal anti-GFAP antibody (1:400, Invitrogen Life technologies, 
Stockholm, Sweden) at 4°C for 20h. GFAP was detected with an Alexa 546 goat anti-
rat IgG secondary antibody (1:800, Invitrogen Life Technologies, Stockholm, Sweden) 
at RT for 1h. After treatment with primary and secondary antibodies, sections were 
incubated in p-FTAA working solution diluted 1:500 in PBS at RT for 30 min. 
Incubation in BOBO-1 solution followed (1:1000, Invitrogen Life Technologies, 
Stockholm, Sweden) in PBS at RT for 30 min. Sections were finally mounted in Dako 
mounting solution for fluorescence (Dako, Glostrup, Denmark) and kept at 4°C until 
imaged. 
 
Fluorescence microscopy 
High resolution images from the immunostained brain sections were acquired using a 
ConfoCor3 system (Carl Zeiss, Jena, Germany), consisting of an inverted microscope 
(Axiovert 200 M) coupled to a VIS-laser module comprising the tunable Ar/ArKr (458, 
477, 488 and 514 nm), HeNe 543 nm and HeNe 633 nm lasers and a scanning module 
LSM 510 META. The instrument was specially modified to enable fluorescence 
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detection in the imaging mode using silicon avalanche photodiodes (SPCM-AQR-1X; 
PerkinElmer, USA).  
 
p-FTAA imaging and quantification 
p-FTAA quantification was accomplished by recording the fluorescence from the Aβ 
deposits with an epifluorescence microscope Leica DM6000 B (Leica, Wetzlar, 
Germany) equipped with a SpectraCube (optical head) module (Applied Spectral 
Imaging, Migdal Ha-Emek, Israel), with the 405/20 and 535/50 longpass filters. Spectra 
were quantified using the standard software (SpectraView). Furthermore, high 
resolution p-FTAA imaging was accomplished using the ConfoCor 3 system described 
above. In brief, the green component of the emitted p-FTAA fluorescence was 
collected using the band pass filters BP 505-530 and BP 530-575, whereas the red 
component was collected using the long pass filter LP 580. Plan-Apochromat 5x/0.16 
and C-Apochromat 40x/1.2 W objectives were used throughout. Images were recorded 
at 512x512 pixel resolution and processed using the standard software (LSM Image 
Browser). 
 
Confocal microscopy of immunostained sections 
Imaging of sections immunostained with GFAP and Iba1 (together with p-FTAA and 
BOBO-1 staining) was accomplished using the ConfoCor 3 system described above. 
A multi-track configuration was used for fluorescence imaging, acquiring the signal 
for one fluorophore at a time. BOBO-1 fluorescence was excited using the 458 nm 
line of Ar/ArKr laser, and the emitted light was collected through a band pass filter 
BP 470-495 nm (pseudo-colored blue); p-FTAA fluorescence was excited using the 
488 nm line of the Ar/ArKr laser, and the emitted light was collected through a band 
pass filter BP 505-530 nm (pseudo-colored green) and a long pass filter LP 580 nm 
(pseudo-colored red); GFAP was visualized through the Alexa 546-bound anti-GFAP 
antibody, Alexa 546 fluorescence was excited using the HeNe 543 nm laser and the 
emitted light was collected through a band pass filter BP 560-610 nm (pseudo-
colored green); Iba1 was visualized through the Alexa 633-bound anti-Iba1 antibody, 
Alexa 633 fluorescence was excited using the HeNe 633 nm laser and the emitted 
light was collected through a band pass filter BP 655-710 nm (pseudo-colored red). 
Plan-Apochromat 5x/0.16 and C-Apochromat 40x/1.2 W objectives were used 
throughout. Images were recorded at 512x512 pixel resolution and processed using 
the standard software (LSM Image Browser). Fluorescence images from large brain 
areas were composed by aligning a number of 318x318 μm2 images (acquired with 
the 40x objective) using the open source vector graphics editor Inkscape (available at 
www.inkscape.org). High resolution ToF-SIMS images and fluorescence images 
(acquired for the adjacent immunostained sections) were overlaid using Inkscape, and 
matched areas were localized. GFAP and Iba1 fluorescent immunostainings were 
quantified in these matched areas, using ImageJ (available at imagej.nih.gov).  
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Scanning-electron microscopy (SEM) 
The Tg2576 brain section studied with ToF-SIMS and CLSM was thereafter analyzed 
using SEM in order to investigate the morphological structure of previously imaged 
senile plaques. Immediately before SEM analysis, the tissue section was rinsed in PBS, 
in order to demount it from the fluorescent mounting media, and air dried. SEM 
analysis was carried out on the uncoated tissue sample in a Zeiss Supra 40VP FEG 
microscope (1 keV electron energy, 5 mm working distance) using an Everhardt-
Thornley secondary electron detector. 
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RESULTS AND DISCUSSION 
 
The following section briefly summarizes and discusses the major findings obtained in 
papers I-IV, in the perspective of the thesis as a whole. The reader is asked to refer to 
the individual articles for the actual results including additional data as well as detailed 
images and statistics. 
 
TEMPERATURE VARIATIONS, TISSUE STAINING AND LIPID 
REDISTRIBUTION 
 
We have analyzed several types of biological tissue using ToF-SIMS. During our 
experiments, the distribution of most substances on the cut tissue surface analytes has 
shown a dependence on certain analysis conditions, temperature and tissue treatment 
being the most important ones. 
 
Temperature (unpublished) 
ToF-SIMS analysis of biological tissue sections provides the distribution of numerous 
surface analytes. As will be discussed in the following sections, most analyses aimed at 
investigating the distribution of Ch in brain tissue of animal models of AD. During 
ToF-SIMS measurements, we observed important variations in the surface distribution 
of Ch that were associated with temperature variations.  
Figure 4-1 displays the ToF-SIMS analysis and subsequent CLSM imaging of a region 
occupied by senile plaques in the subiculum of a 3xTg-AD mouse brain section. Figure 
4-1a displays the BOBO-1 cell nuclei marker staining (pseudo-colored red) and p-
FTAA amyloidotropic fluorescent dye staining (pseudo-colored yellow). The white and 
green squares delineated in the image were previously analyzed with ToF-SIMS, 
generating TIM surface images (Figs. 4-1b and 4-1d) and Ch (Fig. 4-1c and 1e) images 
of the areas scanned. Despite being acquired at the same region, the distribution of Ch 
displayed in Fig. 4-1c presents a homogeneous profile whereas the Ch pattern displayed 
in Fig 4-1e is much more heterogeneous. It was known before that temperature affects 
ToF-SIMS measurements; the changes in analyte distribution, however, were 
considerable in the experiments for this thesis.  
Variations in the surface distribution of Ch are probably due to the fact that lipids and 
other analytes may diffuse from inner layers of the tissue sections (Sjövall et al., 
2006) and reach the surface through micro orifices generated during the freezing 
and/or cryosectioning processes, which account for most artifacts generated during 
preparation and handling steps. Figure 4-2 displays the signal variations displayed by 
some ions measured from freeze-dried mouse brain tissue as a function of sample 
temperature. 
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Figure 4-1. The distribution of Ch at the tissue surface undergoes redistribution upon temperature variations. (a): 
CLSM image from a 3xTg-AD mouse brain section displays the p-FTAA staining of senile plaques (yellow) and 
BOBO-1 staining of cell nuclei (red). The regions delineated with white and green squares include stratum oriens and 
subiculum of hippocampus and were analyzed with ToF-SIMS at -80°C and +23°C, respectively. (b-c): ToF-SIMS 
images acquired in the region delineated with a white square in (a) display the (b) TIM and the (c) Ch distributions in 
the area recorded at -80°C. Note that Ch presents a homogeneous profile over the entire region analyzed. The black 
arrow in (b) highlights a senile plaque. (d-e): ToF-SIMS images acquired in the region delineated with a green square 
in (a), display the (d) TIM and (e) Ch distributions of the area analyzed at +23°C. Note that the Ch has been 
redistributed in (e), as compared to (c). White scale bar (e): 100 μm. 
 
 
 
 
Figure 4-2. Normalized signal intensities of selected ions in ToF-SIMS spectra from freeze-dried mouse brain 
sections. Signal intensities of Ch, ST, phosphatidylinositol (PI) and phosphatidylcholine (PC) ions are measured in a 
Ch-rich area (anterior commissure) as a function of sample temperature upon heating from -130°C to 50°C. Note that 
Ch signal dramatically increases when measuring at temperatures above 0°C, whereas all other analytes display a 
progressive signal decrease with decreasing temperature. Reproduced from Sjövall et al. (2006) with permission of 
Elsevier. 
  
 
The literature on ToF-SIMS analysis of Ch in biological tissue is extensive (Touboul 
et al., 2004; Brunelle et al., 2005; Touboul et al., 2005; Debois et al., 2009; Brulet et 
al., 2010). However, in these works, tissues have seldom been analyzed at low 
temperature. As shown here, the distribution of Ch may undergo considerable 
redistribution as a function of sample temperature. Therefore, handling and analysis 
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of biological tissues at low temperatures should be taken into consideration in future 
ToF-SIMS work. In the present thesis, an extensive work dealing with ToF-SIMS 
analysis of brain tissue sections is presented. Since previous studies and pilot 
experiments indicated large temperature effects, and in order to reduce lipid diffusion, 
biological tissue was maintained at -20°C during cryosectioning and tissue sections 
were stored at -20°C. Furthermore, most ToF-SIMS measurements on mouse and 
human brain tissue were carried out at -80°C, as described in the experimental 
section.  
 
Staining of tissue sections with osmium tetroxide (paper I) 
The study of biological tissue using light or electron microscopy usually requires 
fixation and staining in order to preserve the material during the processing. Different 
fixatives cause different chemical modifications and alter the physical status of the 
tissues. Osmium tetroxide (OsO4) is extensively used to stain and fix tissues for 
electron microscopy (Studer et al., 2008) and to monitor the distribution of 
unsaturated lipids in electron and optical microscopy of cells and tissues. The gradual 
tissue blackening upon incubation with OsO4, especially during the dehydration step 
through ethanol, is a commonly observed phenomenon. The OsO4 binding to 
unsaturated fatty acid double bonds alone does not give rise to a color switch in the 
stained tissue; the characteristic orange/brown/black “osmium blacks” color is instead 
generated by the products from the osmium ester reduction, forming a high 
accumulation of osmium in the stained tissue region.  
We investigated the localization of osmium oxide and specific lipids in mouse 
adipose tissue by using ToF-SIMS. Osmium species, saturated and unsaturated fatty 
acids and protein-related ions were independently monitored. Before osmium 
incubation, saturated and unsaturated fatty acid, diacylglyceride (DAG) and 
triacylglyceride (TAG) ions were mainly colocalized in specific structures, most 
likely corresponding to TAG deposits in the adipose tissue. Figure 4-3 presents ToF-
SIMS spectra recorded prior to OsO4 staining (Fig 4-3a), after OsO4 staining (Fig 4-
3b) and after OsO4 staining and subsequent ethanol rinsing (Fig. 4-3c). DAG and  
monoacylglyceride (MAG) associated peaks are strong before staining and display 
increased intensity after staining and ethanol rinsing, whereas peaks associated with 
proteins (pc) display decreased intensity after staining and rinsing steps. Figure 4-4 
presents the distribution of saturated and unsaturated fatty acids as well as osmium 
oxide before (Figs. 4-4a to 4-4c) and after OsO4 staining (Figs. 4-4d to 4-4i) and 
subsequent ethanol rinsing (4-4j to 4-4o). After osmium staining, two forms of 
osmium oxide (type I and type II) were observed in the ToF-SIMS spectra and on the 
tissue surface that were associated with different spatial distributions and different 
Os/O ratios. Type I osmium oxide presented an inhomogeneous distribution without 
topographic features and was monitored by the OsO3 ion (Fig. 4-4i). In contrast, type 
II osmium oxide (not shown in the figure) displayed a particle-like distribution with 
topographic features and was monitored by ion clusters of the form OsO3(OsO)n 
suggesting a less oxygen rich oxide than the type I osmium oxide.  
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from ions characteristic for phospholipids and proteins. 
 
 
 
 
 
 
 
 
 
Figure 4-3. ToF-SIMS spectra from analysis of mouse adipose tissue. (a): spectrum recorded prior to OsO4 
staining displays strong signal from monoacylglyceride (MAG), dyacylclyceride (DAG) and phosphocholine (pc) 
ions representing the head group of phosphatidylcholine or sphingomyelin. (b-c): spectrum recorded in a similar 
region of the tissue after (b) OsO4 staining and after (c) staining and subsequent ethanol rinsing display increased 
MAG and DAG signal but reduced pc signal as compared to (a). The inset shows an expanded region of the 
spectrum highlighting the different DAG-related peaks. Reproduced from Bélazi et al. (2009) with permission of 
Springer Link. 
 
Unsaturated C18 fatty acids (C18:1 and C18:2), and DAGs containing these fatty 
acids were found to be colocalized with type I osmium oxide (Figs. 4-4h and 4-4i), 
while the saturated C18 fatty acid and C16 (saturated and unsaturated) fatty acids, and 
DAGs containing these fatty acids, displayed complementary localizations as 
compared to the type I oxide (Fig. 4-4d to 4-4f, 4-4g). Furthermore, fragment peaks 
assigned to proteins and phospholipids showed a strong decrease in signal intensity 
after OsO4 incubation, indicating that a considerable fraction of the proteins and 
phospholipids were removed from the tissue surface during the OsO4 incubation (Fig. 
4-3b/c). However, the remaining proteins and phospholipids were strongly 
colocalized with type II osmium oxide.  
Interestingly, after ethanol dehydration of the stained tissue, both type I and type II 
osmium oxides as well as the unsaturated C18 fatty acids presented a homogeneous 
distribution in the regions scanned (Fig. 4-4m to 4-4o) , whereas the saturated C18 
and the C16 (saturated and unsaturated) fatty acids chains displayed a comparatively 
inhomogeneous distribution (Figs. 4-4j to 4-4l). 
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Figure 4-4. ToF-SIMS analysis of mouse adipose tissue stained with OsO4 and subsequently rinsed with ethanol. 
 (a-c): ToF-SIMS analysis of a tissue region prior to OsO4 staining provided the (a) distribution of C18:0; the (b) 
inset of the area delineated with a square in (a), which presents very similar spatial distribution compared to the (c) 
distribution of C18:1 in the same region. (d-i): ToF-SIMS analysis of a similar region after OsO4 staining displays 
the (d) C16:0, (e) C16:1, (f) C16:2, (g) C18:0, (h) C18:2 and (i) OsO3 ion distributions of the region. Note that 
OsO3 and C18:2 distributions colocalize spatially whereas C18:0 and all other C16 fatty acid chain ions display a 
complementary localization. (j-o): ToF-SIMS analysis of a region, similar to those previously imaged, after OsO4 
staining and subsequent ethanol rinsing provided the (j) C16:0, (k) C16:1, (l) C18:0, (m) C18:1, (n) C18:2 and (o) 
OsO3 distributions in the area analyzed. Note that OsO3 and unsaturated C18 distributions colocalize spatially and 
display a more homogeneous profile as compared to (h) and (i). Adapted from Bélazi et al. (2009) with permission 
of Springer Link. Scale bar: 100 μm. 
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The observed colocalization between type I osmium oxide and unsaturated C18 fatty 
acids is consistent with the established view that OsO4 binds to unsaturated lipids. 
However, our results also indicate that the osmium oxide binding is considerably 
stronger to unsaturated C18 fatty acids chains as compared to the binding to 
unsaturated C16 fatty acids, which was an unexpected finding. Furthermore, ToF-
SIMS images revealed a strong complementary localization between saturated and 
unsaturated C18 fatty acids after OsO4 incubation, whereas such complementarity 
was not observed prior to staining. This suggests that the OsO4 incubation may give 
rise to some redistribution of lipids in the tissue, at least at the >10 μm length scale. 
However, the macroscopic distribution of osmium oxide found in the tissue after 
OsO4 staining is still likely to reflect the original distribution of unsaturated (C18) 
fatty acids and their associated glycerides. Nevertheless, the fact that a large fraction 
of the proteins and phospholipids originally in the tissue were extracted during the 
OsO4 incubation step together with the increased homogeneity presented by osmium 
oxide and the unsaturated C18 fatty acid chains after ethanol rinsing of the stained 
tissue suggests that important chemical and physical modifications are possible, and 
emphasizes the importance of analyzing non-fixed, chemically preserved biological 
tissue as means of maintaining tissue integrity and surface analyte distribution. 
 
TOF-SIMS ANALYSIS OF AMYLOID-RELATED STRUCTURES (paper II-III) 
 
Given the detailed information provided by ToF-SIMS in terms of spectral 
quantification and lateral distribution of analytes in biological samples, we focused our 
efforts on the study of biological tissue affected by AD.  A first step, however, dealt 
with the analysis of amyloid-related structures in the form of synthetic preparations 
(peptides), followed by a second stage involving the study of biological tissue affected 
by AD. The evaluation of the spectra obtained from ToF-SIMS analysis of opioid and 
amyloid peptides revealed a molecular fragmentation pattern that adjusted to that of 
Collision-Induced Dissociation (CID), which is the way to intentionally drive 
molecular fragmentation in most mass spectrometers equipped with collision-based 
ionization sources. Figure 4-5 shows the ToF-SIMS spectrum obtained from 
fragmentation of the opioid peptide leucine-enkephalin. A number of CID-related 
fragment peaks were observed in the spectrum, namely i) single amino acid fragments 
(immonium ions); ii) multiple amino acid fragments and iii) molecular ions. Immonium 
ions (m/z 0-200) are formed after internal cleavage of the peptide bonds at the N and C 
terminal sites, and provide information about the amino acid composition of the 
peptide. In contrast, multiple amino acid fragments (m/z 150-500) arising from 
cleavage of the peptide backbone skeleton provide information about the peptide 
sequence. Molecular ions arise from the protonation (or deprotonation) of the 
molecular peptide species and provide the molecular mass of the peptide structure. 
Most opioid peptides presented specific spectral fragment fingerprints and their 
sequences and composition could be obtained from the information provided by ToF-
SIMS spectra.  
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Figure 4-5. ToF-SIMS spectrum obtained from analysis of the opioid peptide leucine-enkephalin (YGGFL). 
Immonium ion peaks are labeled with the single amino acid coded letter in the low mass region; multiple amino acid 
fragment peaks are labeled with the corresponding sequence-coding letter in the middle mass region, and the peptide 
molecular ion (protonated form) is labeled as MH+. The inset shows an expanded region of the spectrum highlighting 
peaks from different multiple amino acid fragments. Reproduced from Solé-Domènech et al. (2010) with permission 
of the American Chemical Society. 
 
 
 
 
 
Figure 4-6. Immonium ion profiles obtained from opioid and amyloid peptide preparations provided information 
regarding peptide composition. Amino acids are indicated with the single-letter code on top of each bar. Adapted 
from Solé-Domènech et al. (2010) with permission of the American Chemical Society. 
 
 
Figure 4-6 displays representative immonium ion profiles from opioid and amyloid 
peptides upon ToF-SIMS molecular fragmentation. Amyloid peptide substructures 
Aβ1-11 and Aβ29-40 (not shown) displayed specific spectral immonium and molecular 
ion fingerprints, whereas Aβ1-40 and Aβ1-42 peptides displayed weak but identifiable 
molecular ion peaks in the ToF-SIMS spectra (unpublished data).  
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After evaluation of synthetic amyloid preparations, we approached the study of 
biological tissue affected by AD. Regions occupied by senile plaques in brain tissue 
sections presenting neuropathology were identified as described in the experimental 
section and scanned with the ToF-SIMS instrument. Total ion images (TIMs) generated 
from Aβ regions (by adding, in one single image, the distribution of all secondary ions 
detected within a range of 1-2000 Da, as described in the experimental section) 
provided topographical information about the sample surface (Lee et al., 2011). In the 
TIMs, Aβ regions presented a number of dark features that appeared to be protrusions 
from the tissue surface (Fig. 4-7a), with sizes in the range of 20-50 μm in diameter 
that were identified as plaques by subsequent p-FTAA Aβ staining (pseudo-colored 
blue, Fig. 4-7b). The Aβ deposits did not produce any chemically specific signals in 
the ToF-SIMS spectra, as would have been expected from their deviating composition 
compared to the surrounding tissue. Instead, as shown in the TIMs, the inner areas of 
the plaques presented very low ion signal, indicating a significantly decreased yield 
of all secondary ions.  
 
 
 
Figure 4-7. ToF-SIMS and SEM analysis of a region occupied by a senile plaque. (a-b): ToF-SIMS TIM image 
reveals a (a) surface feature with protrusion-like structure identified as a senile plaque by subsequent (b) p-FTAA 
staining, overlaid on top of the TIM image. (c): SEM analysis of the same region reveals a fibrillary deposit 
matched with the senile plaque presented in (a,b). Scale bar: 20 μm. 
 
Signal variations due to topographic features on the surface are a well-known effect 
in ToF-SIMS and are mainly caused by the limited angular acceptance of the analyzer 
(Lee et al., 2011). In order to confirm the topographic nature of the plaques, Aβ 
regions analyzed with ToF-SIMS were subsequently imaged using SEM. Indeed, 
plaque regions visualized with SEM revealed the presence of fibrillary bodies that 
matched the surface protrusions observed in the ToF-SIMS TIMs (Fig. 4-7c), thus 
confirming the topographic protrusion-like nature of Aβ deposits on the tissue 
surface. Hence, the observed low secondary ion yield may primarily be a topographic 
effect. 
Taken together, ToF-SIMS analysis of Aβ revealed structure-related fingerprints in 
the spectra obtained from synthetic preparations, whereas the study of extracellular 
Aβ deposits in brain tissue revealed surface-related Aβ features with no specific 
spectral fingerprints. 
Santiago Solé Domènech 
38 
SIMULTANEOUS SPATIAL IMAGING OF CHOLESTEROL, GLIAL CELLS 
AND AMYLOID-BETA (paper IV) 
 
The diverse units that compose biological structures possess a natural interactive role 
with each other. Therefore, tools that provide the opportunity to simultaneously study 
these biological units might provide a more accurate picture of the biological events 
occurring in health and disease. After having learned ways to detect and analyze 
regions undergoing plaque deposition, we decided to study the lipid profile of these 
areas affected by neuropathology. Furthermore, given the fact that glial cells play a key 
role in the synthesis, transport and recycling of lipids in the central nervous system, we 
needed to develop a method that would allow for simultaneous spatial study of lipids 
and glial populations. However, the combination of techniques that allow study of lipid 
profiles or proteins is challenging. With those caveats in mind, we combined ToF-
SIMS imaging of lipids and molecular fragments in mouse and human brain structures 
affected by AD pathology with confocal fluorescence imaging of glial proteins and 
deposits of Aβ, in order to study these biological units at the same location of a 
particular tissue section.  
Most immunolabeling protocols require previous fixation of tissues (usually by 
perfusion) in order to stabilize cell morphology and disable proteolytic enzymes, as 
well as to prevent the detection of hematologic antigens. The application of chemical 
fixatives may substantially alter the chemical composition of the tissue sections, thus 
hampering or even preventing their subsequent analysis using other complementary 
techniques. In early preliminary experiments, the application of fixatives to the tissues 
subjected to ToF-SIMS analysis hampered the experiments, causing the so-called 
matrix effects (Piwowar et al., 2009). In order to prevent for such effect, fresh frozen 
tissues were used in essentially all subsequent analysis for this thesis. 
Furthermore, multiple immunolabeling of fresh frozen non-fixed tissues is not trivial. 
In the present approach, tissues analyzed with ToF-SIMS were subsequently 
immunostained with Iba1, GFAP, BOBO1 and p-FTAA in order to visualize 
immunoreactive astrocytes, immunoreactive microglia, cell nuclei and extracellular Aβ 
deposits. The fact that tissue sections do not suffer any major damage during ToF-
SIMS analysis, as only the uppermost molecular layers (approximately 10 nm) are 
affected, together with the possibility of analyzing the samples at -80°C, helped in 
preserving the tissue’s structural and chemical integrity. Astrocyte and Aβ labeling 
with GFAP and p-FTAA did not involve any additional difficulty, despite of having 
to perform the immunolabeling in fresh frozen tissue. However, Iba1 immunostaining 
was only successfully performed provided that long post-fixation (up to 2 hours) and 
incubation (up to 17 day) steps were carried out.  
Figure 4-8 displays a representative example of a region occupied by a senile plaque 
successfully analyzed with the combined methodology. Figures 4-8a and 4-8b present 
the TIM and Ch distributions whereas Figs. 4-8c and 4-8d display the GFAP (green) 
and Iba1 (red perinuclear staining) immunostainings together with BOBO-1 (blue) and 
p-FTAA (yellow) stainings of the region. At the current stage, no direct correlation 
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between the Ch profile and glial cell distribution was found. Note that Fig. 4-8b 
displays a granular Ch distribution; interestingly, regions occupied by senile plaques 
usually presented severe Ch granulation. The evaluation of Ch profiles will be 
discussed in the following section. 
 
 
 
Figure 4-8. ToF-SIMS analysis of 3xTg-AD hippocampus combined with GFAP and Iba1 immunostaining of 
reactive astrocytes and microglia. (a-b): ToF-SIMS analysis of a region occupied by a senile plaque displays the 
(a) TIM and (b) Ch distribution of the area. The senile plaque was stained with p-FTAA (pseudo-colored blue, 
overlaid on top of (a) and (b)). Note that Ch presents a granular distribution widespread over the area scanned.  
(c): Confocal fluorescence images of the same region analyzed with ToF-SIMS in (a) and (b) displays the (c) 
GFAP immunostaining (pseudo-colored green) of reactive astrocytic processes and (d) Iba1 immunostaining of 
reactive microglia, together with p-FTAA (pseudo-colored yellow) and BOBO-1 (pseudo-colored blue) staining of 
Aβ and cell nuclei. ToF-SIMS images were acquired with the instrument optimized for maximum spatial 
resolution. Scale bar: 20 μm. 
 
Importantly, the combined methodology allowed for simultaneous spatial imaging of 
Ch, glia and Aβ deposits with great lateral (<400nm) resolution. Imaging of lipids and 
glial populations at the same spatial localization and with such remarkable resolution 
might provide a more accurate measure of how these components interact, as compared 
to studies conducted in adjacent or semi-adjacent sections.  
Provided that some precautions are taken, the technique is capable of processing a wide 
range of biological tissues. Hence, experimental research dealing with the study of lipid 
composition, lipid turnover and impaired lipid metabolism, not only in brain tissue but 
in other types of biological samples might benefit from the combined methodology 
developed. Given the fact that ToF-SIMS allows for analysis at low temperatures, 
tissue sections may even be subsequently studied with in-situ hybridization methods or 
other techniques specifically oriented to determine gene expression profiles and RNA 
levels in tissue, thus providing a tool to investigate the relationship between lipid 
profiles and gene expression. 
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REGIONS UNDERGOING SENILE PLAQUE DEPOSITION EXHIBIT 
CHOLESTEROL GRANULATION (paper III-IV) 
 
Having become experienced with the analysis of biological tissue affected by AD 
pathology using MSI and confocal immunohistochemistry, we proceeded to investigate 
the brain lipid profile of the 3xTg-AD and Tg2576 mouse models using the combined 
methodology. The present section deals with the study of Ch profiles in 3xTg-AD and 
Tg2576 mouse brains, whereas the coming chapters will discuss the study of tissue 
sections using fluorescence techniques.  
Regions undergoing plaque deposition in 3xTg-AD and Tg2576 brains were localized 
as described in the experimental section, and Ch images were generated from several 
areas undergoing plaque deposition. Figure 4-9 displays the ToF-SIMS analysis of a 
region located in the molecular layer of hippocampus, for Tg2576. The region is 
occupied by senile plaques presenting protrusion-like characteristics (Fig. 4-9a). In the 
area, the distribution of Ch presents a highly inhomogeneous profile (Fig 4-9b). 
Generally, hippocampal regions occupied by Aβ displayed abundant Ch deposits with 
granular distribution, ranging 2-9 μm in diameter, not only in Tg2576 but also in 
3xTg-AD brains. Ch granules did not exclusively colocalize with Aβ but were rather 
widely spread over the areas analyzed. Some Aβ regions displayed severe Ch 
granulation whereas others presented a more discrete sterol accumulation pattern, 
perhaps not associated with a pathological event. Figure 4-9c displays a region 
similar to the hippocampal area analyzed for Tg2576, but in a matching WT mouse 
brain. In the area, Ch presents a homogeneous distribution, lacking major 
accumulations. In fact, most regions devoid of plaques (not only in WT but also in Tg 
mice) presented reduced or no sterol accumulation; 3xTg-AD brain regions including 
corpus callosum and stratum oriens of hippocampus as well as some cortical regions 
displayed a generally homogeneous Ch distribution, whereas only a very limited 
number of areas presented Ch granulation.  
 
 
 
Figure 4-9. ToF-SIMS analysis of Tg2576 and WT hippocampus. (a-b): ToF-SIMS analysis of an area occupied 
with a senile plaque in the molecular layer of hippocampus (3xTgAD) displays the (a) TIM and (b) the distribution 
of Ch in the region.  Note that the TIM presents a protrusion-like structure (highlighted by a black arrow) that was 
identified as a senile plaque by subsequent p-FTAA staining (not shown), whereas the distribution of Ch in (b) 
presents a granular profile. (c): ToF-SIMS analysis of a WT hippocampal area spatially matched to the region 
analyzed in 3xTgAD. Note that the distribution of Ch is homogeneous. The images were acquired with ToF-SIMS 
optimized for maximum image resolution. Scale bar: 20 μm. 
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Similarly, a preliminary ToF-SIMS study conducted in WT control brains (age-
matched to 3xTg-AD) presented a generally homogeneous Ch distribution in areas 
spatially matched to those regions studied in 3xTg-AD, and only a very limited 
number of areas in WT presented Ch granulation.  
In contrast, a limited number of senile plaques in both 3xTg-AD and Tg2576 
hippocampal areas presented local Ch accumulations only, localized at the plaque-
tissue junction, as shown in Fig. 4-10. The sterol may diffuse from inner tissue layers 
and exit to the surface through micro orifices at the plaque-tissue junction, produced 
during the cryosectioning process. In fact, as seen in the previous section, plaques 
possess a shape similar to large dense blocks inserted within tissue layers, and their 
structural and chemical properties differ substantially from those of the surrounding 
tissue (Knowles and Buehler, 2011). Sectioning may probably cause certain bending or 
physical stress to the deposits, pulling them inside-out and causing damage to the 
surrounding tissue, likely to cause damage at the tissue-plaque junction and facilitate 
the diffusion of small amounts of sterol. 
 
 
 
 
 
Fig 4-10. Representative example of plaques showing local Ch accumulation in their vicinities. (a): ToF-SIMS 
analysis of a 3xTg-AD brain area located in hippocampal subiculum displays multiple discrete Ch deposits in close 
proximity to the two central Aβ deposits (pseudo-colored blue), stained with p-FTAA and overlaid on top of the Ch 
image. (b): analysis of Tg2576 hippocampus revealed local sterol accumulations also in close proximity to a plaque. 
The images were acquired with ToF-SIMS optimized for maximum image resolution. Scale bar: 20 μm. 
 
Interestingly, two regions analyzed in cerebellum and caudate putamen of Tg2576 
revealed the presence of Ch accumulations too; compared to Aβ regions, these 
deposits presented larger sizes (3-19 μm) and lower abundances, with no granular 
distribution, as shown in Fig. 4-11. Caudate putamen and cerebellum of Tg2576 are 
known to undergo amyloidogenesis, but at much reduced rates compared to 
hippocampal and cortical regions (Hsiao et al., 1996). Therefore, besides being 
presumably indicative of an on-going AD-related event, granules could also monitor 
inherent differences in sterol content between different regions, not necessarily 
associated with pathology. Hence, areas with increased granulation may monitor 
locally elevated Ch levels and/or even enhanced lipid redistribution due to neuronal 
reinnervation (Poirier et al., 1993), whereas regions with reduced or no granulation 
may be indicative of a physiologically normalized Ch content.  
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Figure 4-11. Study of the distribution of Ch in cerebellum and caudate putamen of Tg2576 mouse brain.  
(a-c): CLSM and ToF-SIMS images acquired from a region including caudate putamen display the (a) BOBO-1 
(red) staining of the region, and the ToF-SIMS (b) TIM and (c) Ch distributions of the area delineated with a green 
square in (a). (d-f): similar analysis of a cerebellar region including ansiform lobule provided (d) CLSM images of 
the area stained with BOBO-1, and ToF-SIMS images displaying the (e) TIM and (f) Ch distribution of the 
scanned area. Both regions studied were devoid of mature senile plaques, as confirmed by subsequent p-FTAA 
staining (not shown). Note that Ch forms elongated deposits within regions of increased Ch background, as 
highlighted by white arrows. The images were acquired with ToF-SIMS optimized for maximum image 
resolution. White scale bar: 20 μm. 
 
At the current stage, images acquired with ToF-SIMS are being evaluated visually by 
independent observers. Their task is to determine whether a particular region presents 
a granular or a homogeneous sterol distribution, and to classify it accordingly. 
However, visual assignment of images into categories is not trivial, and the inherent 
patchy characteristics of most Ch profiles recorded with ToF-SIMS make it difficult 
for an observer to be absolutely certain of the fact that a region indeed displays a 
purely homogeneous or a purely granular Ch profile. Therefore, we are now aiming at 
implementing automated quantification procedures such as those used in ImageJ or 
other specialized software. A first step will consist in defining the visual 
characteristics of the “cholesterol granule” in terms of number of pixels and intensity 
and to further quantify the images according to these criteria. 
The Ch granules observed in regions undergoing plaque deposition resemble myelin 
fragments. Indeed, it is known that regions undergoing myelin degeneration display Ch 
ester crystals, as show in Fig. 4-12a (Miklossy and Van der Loos, 1987), and focal 
demyelination exclusively related to areas occupied by Aβ plaques has been observed 
in both human and Tg2576 brain (Mitew et al., 2010). Poirier et al. described the 
accumulation of phospholipids and Ch esters in the molecular layer of hippocampus 
following entorhinal cortex lesion in rats (Poirier et al., 1993). The molecular layer of 
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hippocampus, stained with Sudan Black, presented a granular pattern similar to that of 
most regions analyzed with ToF-SIMS. Furthermore, Wirths et al. described an age-
dependent axonal degeneration in the APP/PS1 mouse model of AD that may be 
associated with intraneuronal oligomeric Aβ production. Interestingly, regions in spinal 
cord of APP/PS1 presented numerous white matter ovoids with diameters similar to the 
Ch deposits observed in ToF-SIMS images, as shown in Fig. 4-12b (Wirths et al., 
2007). Besides, the inflammatory events and later neurodegenerative status of the AD 
brain leads to formation of myelin fragments in affected areas (Akiyama et al., 2000).  
 
 
 
 
 
 
 
  
 
 
 
 
According to the evidence, the Ch deposits observed in regions occupied by plaques 
could presumably monitor an on-going demyelination process (not necessarily 
associated with neuronal loss) that may be related to the amyloidogenic process itself. 
Late stages of AD are characterized by a pronounced neuronal cell loss accompanied 
by the resulting demyelination process. However, the question is whether myelin 
damage occurs also at very early stages of AD, and whether Aβ species (presumably 
oligomeric units) would be involved in the event. Interestingly, Aβ1-42 fibrils have been 
identified intra-synaptically in the Tg19959 mouse model of AD at already 2 months of 
age (prior to plaque formation) causing degeneration of spines and neurites (Capetillo-
Zarate et al., 2011).  
The next step will be to determine the exact nature of the sterol accumulations observed 
in regions undergoing plaque deposition. Furthermore, ToF-SIMS study of brain 
regions affected by Aβ pathology in animal models, at early stages of AD, might 
provide valuable information regarding the presumably altered lipid status associated 
with AD pathogenesis. 
 
 
Figure 4-12. Brain regions undergoing myelin loss or neurodegeneration display specific staining features.  
(a): formalin-fixed human brain tissue section displays a region affected by infarction. Macrophages loaded with 
birefringent Ch ester crystals occupy the entire degenerated area. Abbreviations: VPL-ventral posterolateral 
nucleus of thalamus; IC-left internal capsule. Scale bar (white): 1mm. Reproduced from Miklossy et al. (1987) 
with permission of Elsevier. (b): Toluidine blue stained sections of the cervical spinal cord with numerous white 
matter ovoids in a 10-month-old APP/PS1ki mouse. Scale bar (red): 33μm. Reproduced from Wirths et al (2007) 
with permission of Elsevier.  
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SENILE PLAQUES PER SE MAY NOT BE INVOLVED IN THE 
CHOLESTEROL GRANULATION PHENOMENON (paper IV) 
 
A number of 3xTg-AD mouse brain sections analyzed with ToF-SIMS were 
subsequently studied using fluorescent techniques. At that stage, we decided to 
investigate the relationship between senile plaque structure and Ch granulation. In order 
to do so, we studied the structure and chemical composition of the extracellular Aβ 
deposits using the amyloidotropic dye p-FTAA, and correlated it to the Ch profile 
associated with each individual plaque, provided by ToF-SIMS. Those tissue sections 
previously analyzed with ToF-SIMS were subsequently stained with p-FTAA. 
However, given the fact that the p-FTAA protocol requires ethanol fixation, we could 
not perform an optimal GFAP staining on those sections. Therefore, the study of glial 
cell populations was carried out on sections adjacent to those subjected to ToF-SIMS 
analysis, and regions undergoing plaque deposition in both adjacent sections were 
overlaid. The study of glial populations and Ch profiles in overlaid brain regions will 
be discussed in the following section.  
A number of early studies suggested that extracellular Aβ deposits were the main toxic 
units and key players in the development of AD (Dickson, 1997). However, later 
revision of the amyloidogenic cascade theory suggested that those toxic units may not 
be the senile plaques but the oligomeric Aβ units (Walsh et al., 2002; Haass and Selkoe, 
2007; Selkoe, 2008). In order to investigate the involvement of Aβ in the observed Ch 
granulation phenomena, extracellular Aβ plaques in regions undergoing Ch granulation 
were stained with the amyloidotropic fluorescent dye p-FTAA and compared to 
plaques in regions with reduced or no granulation. Upon binding to Aβ, p-FTAA emits 
fluorescence at specific wavelengths (emission modes) that have their origin in the 
properties of the aggregated Aβ to which the dye binds; p-FTAA fluorescence emission 
from diffuse regions of the plaques is shifted towards longer wavelengths, whereas p-
FTAA bound to more condensed regions emits towards shorter wavelengths (Åslund et 
al., 2009), as show in Figs. 4-13 and 4-14. 
If senile plaques were to be involved in the Ch granulation process, their structure-
related p-FTAA properties (associated with plaque density and chemical 
composition) should presumably differ depending on which Ch-type of area they are 
located. Indeed, it is known that some Aβ deposits with diffuse structure display 
increased cytotoxicity (Yoshiike et al., 2007) and may release oligomeric species 
more actively (Haass and Selkoe, 2007). Recently, a study showed that Aβ deposits in 
an animal model of AD carrying the human arctic mutation were enriched in Aβ1-42 
and displayed strong p-FTAA fluorescence shifted towards longer wavelengths (Lord 
et al., 2011). The increase in Aβ1-42 formation enhances oligomer and protofibril 
formation, which causes progressive severe and permanent changes in synaptic 
function (Nilsberth et al., 2001). 
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Figure 4-13.  p-FTAA emission profile of plaques measured in hippocampus and cortex of Tg2576. The spectra are 
divided into two distinct regions, namely “green component” and “red component”. Images of senile plaques stained 
with p-FTAA are usually composed of two channels, a channel, pseudo-colored green, integrating the fluorescence of 
the “green component” of the emission profile, and a channel, pseudo-colored red, integrating the fluorescence of the 
“red” component of the emission profile. The green component of the spectra presents two main emission modes 
(highlighted with green arrows) whereas the red component of the emission profile presents one main emission mode 
(highlighted with a red arrow). In the graphic, two groups of plaques stained with p-FTAA were measured and their 
emission profiles plotted in two groups, namely (1) with intense emission from the green component of the spectrum, 
and (2) with intense emission from the red component of the spectrum. These two distinct emission profiles are 
indicative of structural and chemical differences between the different plaques measured.  
 
 
 
 
Figure 4-14. p-FTAA staining of senile plaques in Tg2576 mouse hippocampus. (a): images displaying a number of 
deposits stained with p-FTAA. Note that some deposits show distinct red and green emission profiles (integrating the 
red and green components of the p-FTAA fluorescence emission spectrum). (b,c): images presenting (b) a senile 
plaque with fluorescence emission shifted towards shorter wavelengths (green) and (c) a plaque with an emission 
profile shifted towards longer wavelengths. Note that the periphery of the Aβ deposit displayed in (c) presents intense 
emission mainly from the red component of the spectrum. Scale bar: 25 μm. 
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Senile plaques in regions analyzed with ToF-SIMS were subsequently stained with p-
FTAA, and their fluorescence profiles measured. We compared the profiles of a 
number of hippocampal mature Aβ deposits present in regions with severe Ch 
granulation to that of mature deposits in regions with discrete or no Ch accumulation. 
However, analysis of profiles did not identify any characteristic structural p-FTAA-
associated difference between plaques, suggesting that extracellular Aβ deposits may 
not be associated with the Ch granulation event.  Assuming the fact that Ch deposits 
may presumably monitor an AD-related process (possibly an on-going myelin loss 
event), the fact that p-FTAA-related structural and chemical properties did not differ 
between plaques measured in areas with discrete or granulated Ch profile is consistent 
with the idea that mature senile plaques per-se may not be most toxic Aβ units.  
 
INCREASED ASTROCYTIC IMMUNOREACTIVITY ASSOCIATED WITH 
CHOLESTEROL GRANULATION  (paper IV) 
 
In an attempt to determine the involvement of glial cells in the Ch granulation event, 
sections adjacent to those analyzed with ToF-SIMS were processed with 
immunohistochemical methods and imaged using confocal microscopy. Antibodies 
against GFAP and Iba1 were used as markers of immunoreactive astrocytes and 
microglia, respectively. Sections were also stained with p-FTAA and BOBO-1 in order 
to visualize extracellular Aβ deposits and cell nuclei, respectively. 
Since GFAP and Iba1 were mainly associated with senile plaques, we decided to 
quantify glial immunoreactivity within circular areas around individual Aβ deposits 
present in regions with severe Ch granulation, and to compare the measurements to 
those from other plaques located regions with discrete or no Ch accumulation. GFAP 
was quantified by measuring the intensity of the staining as integrated density, whereas 
microglia were quantified as the number of Iba1-positive cell nuclei recruited in a 
particular area being quantified. In order to help define and ensure consistency, glial 
immunoreactivity was only quantified for those Aβ deposits conserved between the 
sections subjected to ToF-SIMS analysis and the adjacent immunostained tissues. 
Consequently, only a limited number of senile plaques was measured. 
Figure 4-15 displays a representative example of a region occupied by senile plaques 
undergoing severe Ch granulation. Figures 4-15a and 4-15b display a section analyzed 
with ToF-SIMS and the corresponding immunostained adjacent section, respectively, 
stained with BOBO-1 (red/green) and p-FTAA (yellow). The regions delineated with 
white squares include plaques that were conserved between sections, and were 
therefore quantified for GFAP and Iba1 immunoreactivity. Figure 4-15c to 4-15e 
display ToF-SIMS Ch images acquired from the regions delineated with white squares 
in Fig. 4-15a; the common color arrows in Figs. 4-15b and Figs. 4-15c/d/e indicate 
those plaques spatially matched between adjacent sections. Note that Ch presents a 
granulated distribution in all regions analyzed with ToF-SIMS (Figs. 4-15c/d/e). The 
immunolabeling of the region (in the immunostained adjacent section) displays intense 
Results and Discussion 
47 
GFAP immunoreactivity in regions with intense Ch granulation (identified in the 
section subjected to ToF-SIMS analysis). Areas with a more homogeneous Ch 
distribution displayed reduced GFAP immunoreactivity (for more details, the reader is 
asked to consult paper IV).    
Quantification of glial immunostaining revealed increased GFAP but not increased 
Iba1 immunoreactivity for plaques measured in regions with severe Ch granulation, as 
compared to deposits quantified in regions with a more homogeneous sterol 
distribution. Regions devoid of Aβ, also quantified for glial immunostaining, displayed 
very low glial immunoreactivity, even those areas occasionally found to display severe 
granular Ch distribution. A limited number of areas immunostained in WT mouse brain 
sections, also adjacent to those WT brain sections subjected to ToF-SIMS analysis, 
displayed similar glial immunoreactivity as those regions devoid of Aβ in 3xTg-AD. 
The images acquired for the immunostained WT brain sections are still being 
quantified using ImageJ. 
The significance of the results, however, must be regarded cautiously. First, due to the 
predefined stringent conditions described above, only a limited number of senile 
plaques were quantified in regions with severe Ch granulation (n=12) or homogeneous 
sterol distribution (n=7). Secondly, those plaques that presented both reduced Ch 
granulation and reduced GFAP immunoreactivity were observed in two regions located 
in a single brain section only. However, since all tissue sections were processed 
simultaneously in a consistent way, and since GFAP immunostaining of Aβ regions is 
generally intense, the possibility that the observation could be due to a staining artifact 
is thus improbable. 
Nevertheless, with these caveats in mind, the results offer multiple interpretations. As 
discussed previously, it is known that regions undergoing neuronal loss and/or synaptic 
degeneration display accumulation of lipids and Ch, most likely due to a concomitant 
demyelination event. Astrocytes have been shown to internalize Ch and lipid debris in 
brain areas undergoing neuronal damage (Shobab et al., 2005) and to provide lipids and 
Ch to regions undergoing reinnervation (Poirier et al., 1993). In fact, regions presenting 
synaptic degeneration may undergo massive Ch granulation, which in turn may lead to 
astrocytic recruitment in the affected areas. Indeed, astrocytes, have the capacity to 
accumulate large amounts of lipids, and may simultaneously attempt to recycle lipid 
remnants derived from myelin damage and set the conditions for initiating a 
reinnervation event.  Astrocytes are activated during stroke and CNS trauma (Pekny 
and Nilsson, 2005). However, it is not known whether astrocytic recycling of Ch and 
other lipid debris per se results in increased astrocytic reactivity.  
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Figure 4-15. A 3xTg-AD hippocampal region presenting elevated GFAP immunoreactivity and severe Ch 
granulation. (a,b): CLSM images displaying the  BOBO-1 (red/green) and p-FTAA (yellow) staining of (a) a section 
previously analyzed with ToF-SIMS and (b) the adjacent immunostained section. The white squares highlight 
common regions occupied with senile plaques. (c-e): ToF-SIMS images displaying the distribution of Ch in the 
regions delineated with white squares in (a). The arrows highlight those plaques that were specifically conserved 
between the two sections. Note that Ch presents a punctate distribution widespread over the entire areas analyzed. (f): 
CLSM image displaying the GFAP immunostaining of the region displayed in (b), which is adjacent to (a). Color 
arrows highlight those plaques that turn up in the adjacent immunostained region, matching the deposits studied in the 
section subjected to ToF-SIMS analysis. Note that the GFAP immunostaining is intense and extensive to the entire 
region displayed. Scale bars: white: 500 μm; red: 20 μm; yellow: 50 μm. 
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In contrast, the number of Iba1-positive cell nuclei recruited did not differ between 
plaques in regions undergoing Ch granulation and areas with reduced sterol 
accumulation. Reactive microglia are known to contribute directly to myelin damage 
through several mechanisms (Akiyama et al., 2000; Minagar et al., 2002), but it is not 
clear whether they are able to release or internalize Ch in significant amounts (Gilardi 
et al., 2009). However, unlike astrocytes, the lipid transport and/or storage capacity of 
microglia may be limited by their reduced cytosolic capacity. In addition, astrocytes 
outnumber microglia (and neurons), thus suggesting their preferential suitability in 
terms of lipid supply, transport and storage. 
 
STUDY OF SULFATIDES IN WHITE MATTER STRUCTURES (paper III-IV) 
 
Besides Ch, other lipid species can be imaged with ToF-SIMS. Previously, several ST 
species have been detected in mouse brain tissue, namely ST 22:0, h24:1, 24:1, h24:0, 
24:0 and h22:0 (Sjövall et al., 2004); the first digit denotes the number of carbon 
atoms and the second the number of double bonds of the variable fatty-acid chain, 
whereas h indicates the presence of a hydroxyl moiety attached to the structure. The 
various ST species have very similar spatial distributions in all regions analyzed and 
their signal intensities have therefore been added and are used as an index of the ST 
content. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-16. ToF-SIMS analysis of a region including corpus callosum for Tg and WT mouse brains.  
(a): CLSM image of a Tg2576 brain section analyzed with ToF-SIMS and subsequently stained with BOBO-1 (red) 
and p-FTAA (yellow). The dashed square indicates the approximate structures analyzed with ToF-SIMS for Tg2576 
but also for 3xTg-AD and respective WT (for which the area assignment is therefore approximate). (b): ToF-SIMS 
images displaying the distribution of ST for (b1) Tg2576, (b2) WT control (matched to Tg2576), (b3) 3xTg-AD and 
(b4) WT control (matched to 3xTg-AD). Note that the ST content is much lower in corpus callosum of Tg2576 as 
compared to WT, whereas 3xTg-AD and matched WT do not seem to exhibit significantly gross differences in ST 
signal. White scale bar: 100 µm 
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A number of white matter structures from Tg2576, 3xTg-AD and age-matched control 
mice were analyzed using ToF-SIMS in order to investigate possible differences in ST 
content between Tg and WT. We did not acquire high resolution images in the regions 
studied, as we were not aiming at studying the exact distribution of the analytes. 
Instead, we were aiming in identyfing gross differences in ST signal and, for that 
purpose, acquisition of large 500x500 µm images using the high spectral resolution 
mode (bunched mode) seemed more appropriate. 
Figure 4-16 displays a representative example of the ToF-SIMS analysis carried out in 
Tg2576 and 3xTg-AD white matter structures. Figure 4-16a displays a Tg2576 section 
analyzed with ToF-SIMS and subsequently stained with BOBO-1 (red) and p-FTAA 
(yellow). The dashed square highlights the regions analyzed for Tg2576, 3xTg-AD and 
matched controls, which all include corpus callosum. Figure 4-16b displays ToF-SIMS 
ST images scanned within the region highlighted with a square in 4-16a; Tg2576 
(image b1) displays weak ST signal in the corpus callosum, whereas age-matched 
control (image b3) shows much higher signal. Interestingly, 3xTg-AD (image b2) 
displays similar ST ion signal as compared to WT (image b4). Only a limited number 
of regions were analyzed for Tg2576 (in one brain section only), and therefore the 
results obtained for the strain must be regarded as indicative only. However, most white 
matter regions analyzed for 3xTg-AD (including corpus callosum and fimbria of 
hippocampus) did not display significant differences in ST levels compared to WT. 
For the animals studied, Tg2576 displayed increased Aβ load in cortical and 
hippocampal regions compared to 3xTg-AD. It is to mention that the Tg2576 mouse 
included in the study was 24 month old when sacrificed, whereas the 3xTg-AD was 18 
month old. These animals display increased Aβ production upon aging, which may 
partially account for the differences in ST load observed between Tg genotypes. 
Nevertheless, Han and collaborators reported a decrease in ST levels in cortical 
structures of APPswe likely to be mediated by apoE (Cheng et al., 2008). In these 
animals, the onset of cortical ST depletion matched to that of cortical Aβ pathology. ST 
may be involved in the clearance of Aβ in brain regions (Han, 2010), which is 
consistent with the increased Aβ levels observed in regions undergoing ST depletion. 
However, in our studies, no significant plaque deposition was observed in white matter 
structures.  
We have observed low ST levels in grey matter structures for all mouse strains 
analyzed (including WT) as compared to white matter regions, which is a priori 
expected. Interestingly, grey matter areas, which are poorly myelinated as compared to 
white matter structures, seem to be more prone to undergo ST depletion (Han, 2010). 
Therefore, it will be necessary to undertake a detailed imaging study of ST distribution 
in Tg2576 and 3xTg-AD, also including grey matter structures, in order to determine 
whether cortical and other regions affected by Aβ pathology undergo ST depletion. 
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STUDY OF HUMAN TISSUE USING TOF-SIMS (paper III) 
 
Human brain affected by AD was also studied using ToF-SIMS and CLSM. Figure 4-
17 displays a temporal lobe region analyzed with ToF-SIMS and subsequently stained 
with p-FTAA; Fig. 4-17a presents the TIM of a region analyzed, showing abundant 
protrusion-like structures spread over the entire area. Fig. 4-17b displays the 
distribution of Ch in the region, which was correlated with the distribution of NFT in 
the Ch/p-FTAA staining shown in Figure 4-17c –note that p-FTAA has also been 
shown to stain tau deposits (Åslund et al., 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The human AD tissues analyzed displayed abundant Ch accumulations that did not 
correlate with the presence of NFTs. In addition, regions devoid of NFT in AD and 
age-matched non-demented control brain displayed similar Ch accumulations (data not 
shown), suggesting that other factors besides an AD-related event may drive Ch 
deposition in the tissue studied. The size of the Ch accumulations observed in human 
brain ranged 3-19 µm, whereas most Ch granules observed in hippocampal regions of 
Tg2576 and 3xTg-AD mice ranged 2-9 µm. Hence, the Ch accumulation observed in 
both types of tissue may be reflecting different biological or pathological processes. 
Nevertheless, the observed Ch deposits resemble myelin fragments, which is consistent 
with the already known demyelination process that occurs during the course of 
pathology-related neuronal loss (Miklossy and Van der Loos, 1987; Akiyama et al., 
2000; Minagar et al., 2002; Mitew et al., 2010) and normal aging (Teipel et al., 1998; 
Bartzokis, 2004). However, since only one human AD brain section (and the respective 
age-matched control) have been analyzed, the results presented herein must be regarded 
as indicative only. At the current stage, the identity of these Ch deposits remains 
elusive, and more experiments are needed in order to determine the nature of the 
accumulations as well as any existing link between Ch accumulation and 
amyloidogenesis.  
 
Figure 4-17. ToF-SIMS analysis of human brain tissue affected by AD pathology. ToF-SIMS analysis of a temporal 
lobe brain section provided the (a) TIM and (b) Ch images of the area scanned. Subsequent p-FTAA staining of the 
region revealed abundant NFT, as shown in the (c) overlay between Ch shown in (b) and p-FTAA (pseudo-colored 
blue-red). 
Santiago Solé Domènech 
52 
CONCLUSIONS 
 
 
I. The ToF-SIMS study of mouse adipose tissue revealed alterations in the 
distribution of surface lipids upon staining with osmium tetroxide. Furthermore, 
the study of 3xTg-AD brain tissue revealed considerable variation in the 
distribution of surface cholesterol upon changes in temperature, which is 
consistent with previous publications dealing with the variation of lipid ion 
signal as a function of sample temperature. 
 
 
II. ToF-SIMS analysis of opioid and amyloid peptide preparations and further 
study of the spectra revealed specific spectral fingerprints related to structural 
features and demonstrated that SIMS of short length peptides induces a 
fragmentation pattern similar to that of collision induced dissociation. However, 
contrary to expected, the analysis of extracellular amyloid-beta deposits in 
biological tissue affected by Alzheimer’s disease did not reveal any specific 
spectral fingerprints compared to synthetic amyloid peptides, most likely due to 
low secondary ion production associated with the senile plaques. 
 
 
III. ToF-SIMS imaging was successfully combined with fluorescence techniques; 
This multiplexed imaging approach enabled us to simultaneously observe lipid 
and glial cell distributions in regions undergoing senile plaque deposition with 
great lateral (<500 nm) resolution, thus establishing the possibility to study the 
spatial correlation between lipid species and the enzymes/cell types responsible 
for their synthesis and processing. 
 
 
IV. The study of mouse brain tissue areas affected by Alzheimer’s disease 
pathology using the developed methodology revealed Ch granulation in regions 
undergoing senile plaque deposition that correlated with astrocytic activation 
but that neither correlated with microglial activation nor with senile plaque 
structure.  
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FUTURE PERSPECTIVES 
 
ToF-SIMS has been proven capable of providing valuable information of the content 
and distribution of lipids and lipid precursors in pathological and non-pathological 
tissue. Remarkably, specimens analyzed with ToF-SIMS can be subsequently studied 
using complementary techniques, thus offering the possibility to investigate the role of 
multiple biological components (such as lipids, cells and proteins) in a given 
biochemical problem, which would otherwise be virtually impossible with the only use 
of a single, isolated technique. 
 
ToF-SIMS is the central actor of the combined methodology reported in the present 
work, which allowed for the simultaneous spatial study of lipids, lipid precursors, 
misfolded proteins and glial cell populations. In the near future, the method might 
enormously facilitate the understanding of the involvement and interaction of these 
components in neuropathology. Obvious future steps to be given are the study of brain 
tissue from mouse models of Alzheimer’s disease at early stages of disease progression 
(1 to 6 months) in order to determine whether the observed cholesterol granulation 
event occurs prior to plaque formation; the detailed investigation of ST profiles, also at 
early stages of the disease, in order to clarify the relationship between plaque 
deposition and ST depletion, and the use of ToF-SIMS combined with fluorescence 
techniques in the study of other disease-related biological tissue samples. Furthermore, 
the combination of ToF-SIMS with other imaging techniques such as in-situ 
hybridization may provide new insights on the relationship between lipids and lipid 
precursors and regiospecific gene expression. 
 
It is to note that, mainly due to technical limitations associated with the manipulation of 
biological tissue samples, excessive time-consuming data analysis procedures and slow 
data acquisition protocols, the technique has not yet found a broad use for solving 
biochemical problems in medicine and cell biology. In order to give an extended use 
to the methodology, it will be necessary to improve the existing operating protocols in 
order to facilitate data acquisition in a more automated way. In addition, it is of vital 
importance to make the methodology available to the medical research field, in order to 
receive feedback from biology-oriented research staff and being able to optimize the 
instrument for the study of complex biological and medical paradigms. 
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